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I N T RO D U C T I O N  
he Maine Cancer Registry collects information 
on all cancer cases diagnosed in Maine 
according to State Law Title 22, Chapter 
255.  The 2013 annual report is based on 2010 
cancer incidence and 2010 cancer mortality data, 
the latest years for which data were available at 
the time of the analysis. The report provides 
information on the most frequently diagnosed 
cancer types in Maine.   
The purpose of this report is to summarize data on 
newly diagnosed cases of cancer (incidence) and 
deaths associated with cancer (mortality) among 
 
 
Maine residents. Data are presented at the county 
and public health district levels for all cancer types 
combined, the top four cancers in Maine (namely: 
female breast, prostate, lung, and colorectal 
cancers), and tobacco-related cancers combined 
(excluding lung cancer).   
The information contained in this report may be 
used in conjunction with other data sources to 
determine cancer burden and to guide programs 
and policies targeted at reducing the impact of 
cancer.   
 
Summary of Features: The following is a summary of features added to this report in recent years: 
• Charts describing the trends in the mortality due to the top four cancers (namely: female breast, prostate, 
lung, and colorectal cancers), and tobacco-related cancers combined (excluding lung cancer) in Maine are 
provided (See pages 21-22, 36-37). 
• County-level and public health district-level maps of mortality rates for all cancer types combined are 
provided (See pages 39-40). 
• Data are presented for “tobacco-related cancers” and “obesity-related cancers”.  
• Age-specific incidence data are presented for the top four cancer sites in Maine. 
• Data are presented for malignant and non-malignant incident cases of brain and other nervous system 
tumors.  
T E C H N I C A L  N O T E S  
Tobacco-related Cancers:  Tobacco-related 
cancers excluding lung cancer are included in this 
report due to their increasing clinical and 
epidemiologic significance.  According to a 2008 
MMWR surveillance summary (Surveillance for 
Cancers Associated with Tobacco Use — United 
States, 1999–2004), tobacco-related cancers are 
those that are defined by the U.S. Surgeon 
General as having direct causal relationships to 
tobacco use.  The list of tobacco-related cancers 
was expanded in 2004 to include the following: 
lung, laryngeal, oral cavity and pharynx, 
esophageal, stomach, pancreatic, kidney and renal 
pelvis, urinary bladder, cervical cancers, and acute 
myeloid leukemia.   
Obesity-related Cancers: According to the 2007 
expert report published by the World Cancer 
Research Fund and American Institute of Cancer 
Research, there is convincing evidence that greater 
body fat is a cause of adenocarcinoma of the 
esophagus, as well as cancers of the pancreas, 
colon, kidney, endometrium, and breast 
(postmenopausal). Due to the prevalence of 
obesity in Maine, this group of cancers is included 
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Data Sources:  Maine incidence data are obtained 
from the Maine Cancer Registry. Mortality data for 
both Maine and the U.S. is provided by the National 
Center for Health Statistics.  Estimates of national 
incidence data are used for comparisons and are 
derived from the Surveillance, Epidemiology and End 
Results (SEER) Program of the National Cancer 
Institute. The SEER dataset used in this report (SEER 9) 
represents about 9.4% of the U.S. population.   
Data Analysis:  Counts and rates presented in this 
report were produced using the following software: 
Surveillance Research Program, National Cancer 
Institute SEER*Stat software (seer.cancer.gov/seerstat) 
8.0.4. 
National Comparisons:  SEER incidence rates and 
national mortality rates for both whites and all races 
have been provided to allow an option for 
comparison by the reader.  However due to the 
predominately white population in Maine, all 
statistical comparisons in this report involving national 
estimates are based on rates for whites.  These 
estimates appear under the headings “SEER Whites” 
and “SEER All races”.  
Rates:  Incidence and mortality rates are calculated 
per 100,000 population and are age-adjusted to the 
year 2000 U.S. standard population. 
Confidence Intervals and Statistical Significance:  
Ninety-five percent confidence intervals are provided 
for all rates. If the 95% confidence intervals for two 
rates overlapped, the incidence rates were 
considered similar. If the confidence intervals did not 
overlap, we considered these rates to be significantly 
different.  Maine rates that are higher than nationally 
comparable rates or county/district rates that are 
higher than State (Maine) rates are highlighted in 
orange (     ).  
Maine Public Health Districts:  In 2007, the Maine 
Center for Disease Control and Prevention created 
eight public health districts, each district made up of 
one or more counties.  For this reason, cancer rates 
have been calculated for districts in addition to 
counties.  The table above shows the constituent 
counties of each district. 
 
Rates by County/District:  More so than at the state 
level, the number of new cancer cases reported in a 
county or district varies from year to year, and much 
of this variation may be due purely to chance.  As a 
result, cancer rates at the county or district level are 
more likely to vary on an annual basis than at the 
state level.  Counties/districts with smaller 
populations tend to have greater variation from one 
time period to the next.  In general, when there are 
less than 30 cancer cases a year in a geographic 
entity, it can be difficult to distinguish between 
normal variation and meaningful changes in cancer 
rates.  In this report, multiple years of data are 
combined when producing the county or district rates.  
Although combining years can make the rates more 
reliable, caution must still be used when interpreting 
county and district rates because of small 
populations. 
Maps: We have included maps to present the 
geographical distribution of ‘All Cancer Combined’ 
incidence and mortality rates. These maps were 
prepared at the county as well as the public health 
district level. Maps were created using ArcGIS v.10 
software; the ‘natural breaks’ method was used to 
categorize the rates.   
 
 
Public Health District Constituent Counties 
1. Aroostook District Aroostook County 
2. Central District 
Kennebec County, 
Somerset County 
3. Cumberland District Cumberland County 
4. Downeast District 
Hancock County, 
Washington County 
5. Midcoast District 
Lincoln County, Knox 
County, Sagadahoc 
County, Waldo County 
6. Penquis District 
Penobscot County, 
Piscataquis County 
7. Western District 
Androscoggin County, 
Franklin County, Oxford 
County 
8. York District York County 
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Charts: We have included charts describing trends 
in cancer incidence and mortality in the State of 
Maine. The incidence charts show trends in the 
incidence rates of colorectal cancer, cervical 
cancer and female breast cancer from 1995 to 
2010. The mortality charts show trends in mortality 
rates for the top four causes of cancers (lung, 
colorectal, female breast and prostate) and 
tobacco-related cancer from 1969 to 2010. 
Separate cancer mortality trend charts were 
prepared for males and females due to gender-
specific cancers.  
C A S E  D E F I N I T I O N S  
Incidence Case Definitions:  Incidence data are based on SEER site recode ICD-O-3/WHO 2008 definitions, 
version 2008: Available at http://www.seer.cancer.gov/siterecode/icdo3_dwhoheme/index.html. Case 
definitions are included in Appendix 1.  Histologies consistent with Kaposi sarcoma and mesothelioma are 
excluded (where applicable).  







Site ICD-10 Codes 
All Sites C00–C97  
Brain and Other Nervous Systems C70-C72 
Breast C50 
Cervix Uteri C53 
Colon and Rectum C18-C20, C26.0 
Corpus Uterus C54, C55 
Esophagus C15 
Hodgkin Lymphoma C81 
Kidney and Renal Pelvis C64-C65 
Larynx C32 
Leukemia C90.1, C91-C95 
Liver & Intrahepatic Bile Duct C22.0-C22.4, C22.7, C22.9 
Lung and Bronchus C34 
Melanoma of the Skin C43 
Myeloma C90.0, C90.2 
Non-Hodgkin Lymphoma C82-C85, C96.3 







Urinary Bladder C67 
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I N C I D E N C E :  S TAT E  A N D  N AT I O N A L  C O M PA R I S O N S  
Age-adjusted Cancer Incidence Rates by Si te, Maine 2010  
 
Notes:  
•                Maine rate is significantly higher than US White rate 
• Tobacco-related cancers excl. lung = laryngeal, oral cavity and pharynx, esophageal, stomach, pancreatic, kidney and renal 
pelvis, urinary bladder, cervical cancers, and acute myeloid leukemia. These cancers are also reported separately in the table 
• Cancer sites are ordered by descending Maine incidence rates 
• Incidence case definitions are based on SEER Site Recode ICD-O-3/WHO 2008  
• Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable 
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population 
• Abbreviations: AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, Epidemiology, and End Results; Excl. = 
Excluding; Nerv. = Nervous; Intrahep.= Intrahepatic 
 
Data Sources: 
• Maine Incidence: Maine Cancer Registry, 1995-2010 NPCR-CSS submission 
• National Incidence: Surveillance, Epidemiology and End Results, SEER 9  Research Data, Nov 2012 Sub (1973-2010) 
 Total 
 AA Rate (95% CI) Count SEER Whites SEER All races 
All Sites 486.7 (476.1 - 497.6) 8,268 465.4 (462.7 - 468.2) 457.5 (455.1 – 460.0) 
Lung and Bronchus 73.2 (69.2 - 77.4) 1,270 57.8 (56.8 - 58.8) 56.7 (55.8 - 57.5) 
Tobacco-related, Excl. Lung 91.3 (86.8 - 96.1) 1,566 82.4 (81.3 - 83.6) 81.0 (79.9 – 82.0) 
Colon and Rectum 39.4 (36.4 - 42.6) 666 39.2 (38.4 – 40.0) 40.6 (39.9 - 41.3) 
Breast See Page 7 & 8 for gender specific rate 
Prostate See Page 7 for gender specific rate 
Urinary Bladder 27.5 (25.1 - 30.2) 473 23.4 (22.8 – 24.0) 21.1 (20.6 - 21.6) 
Melanoma of the Skin 21.9 (19.6 - 24.5) 352 28.8 (28.2 - 29.6) 23.6 (23.0 - 24.1) 
Non-Hodgkin Lymphoma 21.4 (19.2 - 23.8) 360 21.7 (21.1 - 22.4) 21.0 (20.5 - 21.5) 
Leukemia 17.2 (15.2 - 19.4) 283 14.1(13.6 - 14.6) 13.3 (12.9 - 13.7) 
Kidney and Renal Pelvis 14.1 (12.4 - 16.1) 238 14.7 (14.2 - 15.2) 14.6 (14.2 - 15.1) 
Thyroid 13.5 (11.8 - 15.4) 234 14.5 (14.0 - 15.1) 13.8 (13.4 - 14.3) 
Oral Cavity and Pharynx 12.7 (10.9 - 14.8) 182 11.2 (10.7 - 11.6) 10.8 (10.4 - 11.2) 
Pancreas 12.4 (10.7 - 14.2) 218 11.9 (11.5 - 12.4) 12.4 (12.0 - 12.8) 
Brain and Other Nerv. System 8.0 (6.6 - 9.6) 122 7.1 (6.8 - 7.5) 6.4 (6.1 - 6.7) 
Esophagus 7.0 (5.8 - 8.4) 124 4.5 (4.2 - 4.8) 4.4 (4.1 - 4.6) 
Liver and Intrahep. Bile Duct 5.5 (4.4 - 6.7) 94 6.5 (6.2 - 6.8) 7.9 (7.5 - 8.2) 
Stomach 4.9 (3.9 - 6.1) 88 6.1 (5.8 - 6.4) 7.0 (6.7 - 7.3) 
Myeloma 4.5 (3.6 - 5.6) 80 5.8 (5.5 - 6.1) 6.4 (6.1 - 6.7) 
Larynx 3.3 (2.4 - 4.3) 56 3.1 (2.9 - 3.4) 3.2 (3.0 - 3.4) 
Hodgkin Lymphoma 2.5 (1.7 - 3.6) 34 2.8 (2.6 - 3.1) 2.7 (2.5 - 2.8) 
Mesothelioma 1.7 (1.1 - 2.4) 27 1.1 (0.9 - 1.2) 1.0 (0.9 - 1.1) 
Corpus Uteri See Page 8 for gender specific rate 
Ovary See Page 8 for gender specific rate 
Cervix Uteri See Page 8 for gender specific rate 
Testis See Page 7 for gender specific rate 
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Age-adjusted Cancer Incidence Rates among Males by Site, Maine, 2010 
 
 Male 
 AA Rate (95% CI) Count SEER Whites SEER All races 
All Sites 543.9 (527.3 – 561.0) 4,260   521.4 (517.1 – 525.8) 519.3 (515.4 - 523.2) 
Prostate 121.1 (113.6 – 129.0) 1,022 138.7 (136.5 – 140.9) 145.1 (143.1 - 147.2) 
Lung and Bronchus 83.0 (76.6 - 89.8) 650 66.6 (65.0 - 68.2) 66.8 (65.3 - 68.2) 
Tobacco-related, Excl. Lung 132.8 (124.7 - 141.4) 1,042 118.1 (116.0 - 120.2) 115.0 (113.2 - 116.9) 
Colon and Rectum 45.7 (41.0 - 50.9) 352 45.1 (43.8 - 46.4) 46.6 (45.5 - 47.8) 
Breast 1.8 (0.9 - 3.1) 13 1.1 (0.9 - 1.3) 1.2 (1.1 - 1.5) 
Urinary Bladder 46.0 (41.2 - 51.3) 348 40.9 (39.6 - 42.1) 37.0 (36.0 - 38.1) 
Melanoma of the Skin 27.2 (23.5 - 31.3) 205 35.4 (34.3 - 36.6) 29.6 (28.7 - 30.6) 
Non-Hodgkin Lymphoma 24.5 (21.0 - 28.4) 185 26.6 (25.6 - 27.6) 26.0 (25.2 - 26.9) 
Leukemia 23.5 (20.0 - 27.4) 172 17.4 (16.7 - 18.2) 18.4 (17.6 - 19.2) 
Kidney and Renal Pelvis 20.0 (17.0 - 23.5) 159 20.2 (19.4 - 21.1) 20.4 (19.6 - 21.2) 
Oral Cavity and Pharynx 18.6 (15.7 – 22.0) 155 16.4 (15.7 - 17.2) 16.1 (15.4 - 16.7) 
Pancreas 14.7 (12.0 - 17.7) 115 13.3 (12.6 – 14.0) 13.7 (13.1 - 14.3) 
Esophagus 13.0 (10.5 - 15.8) 105 7.8 (7.3 - 8.4) 7.6 (7.1 - 8.1) 
Brain and Other Nervous System 8.3 (6.4 - 10.7) 65 8.2 (7.6 - 8.7) 7.4 (7.0 - 7.9) 
Testis 8.3 (6.1 - 11.0) 48 6.8 (6.3 - 7.4) 5.8 (5.4 - 6.2) 
Stomach 7.5 (5.7 - 9.8) 62 8.5 (8.0 - 9.1) 9.5 (9.0 - 10.1) 
Myeloma 7.2 (5.4 - 9.5) 54 7.4 (6.9 - 7.9) 8.0 (7.6 - 8.5) 
Liver and Intrahepatic Bile Duct 7.0 (5.3 - 9.2) 58 10.0 (9.4 - 10.6) 12.1 (11.5 - 12.7) 
Thyroid 6.5 (4.7 - 8.7) 47 7.2 (6.7 - 7.7) 6.6 (6.2 - 7.1) 
Larynx 5.3 (3.8 - 7.2) 44 5.5 (5.0 - 5.9) 5.7 (5.3 - 6.1) 
Mesothelioma 2.9 (1.8 - 4.5) 21 2.0 (1.7 - 2.3) 1.8 (1.5 – 2.0) 
Hodgkin Lymphoma 2.7 (1.6 - 4.4) 18 3.3 (3.0 - 3.7) 3.1 (2.8 - 3.4) 
 
Notes:  
•                Maine rate is significantly higher than US White rate 
• Tobacco-related cancers excl. lung = laryngeal, oral cavity and pharynx, esophageal, stomach, pancreatic, kidney and renal 
pelvis, urinary bladder, cervical cancers, and acute myeloid leukemia. These cancers are also reported separately in the table 
• Cancer sites are ordered by descending incidence rates 
• Incidence case definitions are based on SEER Site Recode ICD-O-3/WHO 2008   
• Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable 
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population 




• Maine Incidence: Maine Cancer Registry, 1995-2010 NPCR-CSS submission 
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Age-adjusted Cancer Incidence Rates among Females by Site, Maine, 2010 
 
 Female 
 AA Rate (95% CI) Count SEER Whites SEER All races 
All Sites 446.9 (432.7 - 461.4) 4,008 425.8 (422.1 - 429.5) 413.3 (410.2 - 416.5) 
Breast 123.8 (116.4 - 131.6) 1,113 129.8 (127.7 - 131.8) 126.0 (124.3 - 127.8) 
Lung and Bronchus 66.3 (61.1 - 71.9) 620 51.2 (49.9 - 52.5) 49.2 (48.1 - 50.3) 
Tobacco-related, Excl. Lung 57.9 (52.9 - 63.3) 524 53.7 (52.4 – 55.0) 54.1 (53.0 - 55.3) 
Colon and Rectum 34.2 (30.4 - 38.4) 314 34.3 (33.3 - 35.3) 35.7 (34.8 - 36.6) 
Corpus Uteri 32.1 (28.4 - 36.1) 297 27.8 (26.9 - 28.7) 27.3 (26.5 - 28.1) 
Non-Hodgkin Lymphoma 19.4 (16.5 - 22.7) 175 17.7 (17.0 - 18.5) 16.9 (16.2 - 17.5) 
Thyroid 18.9 (15.7 - 22.5) 135 22.0 (21.1 - 22.9) 20.8 (20.1 - 21.6) 
Melanoma of the Skin 18.0 (15.1 – 21.3) 147 24.2 (23.3 - 25.1) 19.3 (18.6 – 20.0) 
Urinary Bladder 13.1 (10.9 - 15.8) 125 9.9 (9.4 - 10.5) 9.1 (8.6 - 9.6) 
Pancreas 12.7 (10.5 - 15.3) 119 10.8 (10.2 - 11.4) 11.3 (10.8 - 11.8) 
Leukemia 12.5 (10.2 - 15.1) 111 10.7 (10.1 - 11.3) 10.2 (9.7 - 10.7) 
Ovary 10.6 (8.6 – 13.0) 97 13.3 (12.6 - 13.9) 12.6 (12.1 - 13.2) 
Kidney and Renal Pelvis 9.0 (7.1 – 11.4) 79 9.9 (9.4 - 10.5) 9.8 (9.3 - 10.3) 
Brain and Other Nervous System 7.6 (5.6 - 9.9) 57 6.1 (5.7 - 6.6) 5.5 (5.2 - 5.9) 
Oral Cavity and Pharynx 6.7 (5.1 - 8.6) 63 6.3 (5.9 - 6.8) 6.2 (5.8 - 6.6) 
Cervix Uteri 6.5 (4.7 - 8.7) 48 6.5 (6.1 – 7.0) 6.7 (6.3 - 7.1) 
Myeloma 4.2 (3.0 - 5.8) 40 4.5 (4.2 - 4.9) 5.0 (4.7 - 5.4) 
Stomach 2.8 (1.8 - 4.2) 26 4.0 (3.7 - 4.4) 4.9 (4.6 - 5.3) 
Liver and Intrahepatic Bile Duct 2.4 (1.5 - 3.8) 22 3.4 (3.1 - 3.7) 4.2 (3.9 - 4.5) 
Hodgkin Lymphoma 2.3 (1.3 - 3.8) 16 2.4 (2.1 - 2.7) 2.2 (2.0 - 2.5) 
Esophagus 2.0 (1.2 - 3.3) 19 1.7 (1.5 - 1.9) 1.7 (1.5 - 1.9) 
Larynx 1.5 (0.8 - 2.8) 12 1.2 (1.0 - 1.4) 1.1 (1.0 - 1.3) 
Mesothelioma 0.7 (0.2 - 1.6) 6 0.4 (0.3 - 0.5) 0.4 (0.3 - 0.5) 
 
Notes:  
•                Maine rate is significantly higher than US White rate 
• Tobacco-related cancers excl. Lung = laryngeal, oral cavity and pharynx, esophageal, stomach, pancreatic, kidney and renal 
pelvis, urinary bladder, cervical cancers, and acute myeloid leukemia. These cancers are also reported separately in the table 
• Cancer sites are ordered by descending incidence rates 
• Incidence case definitions are based on SEER Site Recode ICD-O-3/WHO 2008   
• Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable 
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population 




• Maine Incidence: Maine Cancer Registry, 1995-2010 NPCR-CSS submission 
• National Incidence: Surveillance, Epidemiology and End Results, SEER 9 Research Data, Nov 2012 Sub (1973-2010) 
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• Incidence case definitions are based on SEER Site Recode ICD-O-3 /WHO 2008 
• Rates are calculated per 100,000 population. 
• Abbreviations: CI = Confidence Interval; Count/Yr = Average Annual Count 
 
Data Sources: 





 Total Male Female 
 Rate (95% CI) 
Count/ 
Yr 
Rate (95% CI) 
Count
/Yr 
Rate (95% CI) 
Count/
Yr 
0-14 years 19.7 (16.5 - 23.4) 44 20.9 (16.4 - 26.4) 24 18.5 (14.1 - 23.8) 20 
15-19 years 20.7 (15.6 - 26.9) 19 21.5 (14.5 - 30.6) 10 19.9 (13.0 - 29.1) 9 
20-24 years 40.1 (32.5 – 49.0) 32 41.0 (30.4 - 54.1) 17 39.1 (28.6 - 52.2) 15 
25-29 years 68.8 (58.3 - 80.8) 50 61.9 (48.0 - 78.6) 22 75.6 (60.2 - 93.8) 28 
30-34 years 102.7 (89.6 - 117.2) 74 75.1 (59.6 - 93.5) 27 129.8 (109.2 – 153.0) 47 
35-39 years 145.3 (130.6 - 161.1) 120 99.0 (82.1 - 118.3) 40 190.3 (167.0 - 216.1) 80 
40-44 years 234.1 (216.6 - 252.7) 220 158.2 (138.0 - 180.6) 73 307.4 (279.4 - 337.5) 147 
45-49 years 388.3 (367.2 - 410.3) 423 302.5 (276.2 - 330.7) 162 471.0 (438.6 - 505.2) 261 
50-54 years 613.3 (586.9 - 640.6) 676 604.4 (567.1 - 643.6) 325 621.8 (584.8 - 660.5) 351 
55-59 years 872.2 (839.3 - 906.1) 881 945.1 (896.2 - 995.9) 466 802.7 (758.7 - 848.5) 415 
60-64 years 1274.8 (1231.6 - 1319.1) 1,095 1448.5 (1383.2 – 1516.0) 616 1104.4 (1048.0 – 1163.0) 479 
65-69 years 1850.8 (1789.7 - 1913.4) 1,157 2156.1 (2061.3 - 2254.1) 649 1567.7 (1490.0 - 1648.4) 509 
70-74 years 2235.0 (2157.8 - 2314.2) 1,056 2772.2 (2646.9 - 2901.9) 613 1762.9 (1669.4 - 1860.2) 443 
75-79 years 2605.7 (2513.9 – 2700.0) 1,013 3193.9 (3041.4 – 3352.0) 548 2140.6 (2029.7 – 2256.0) 465 
80-84 years 2522.5 (2420.6 - 2627.7) 768 3232.3 (3049.8 - 3422.9) 390 2055.9 (1937.9 - 2179.2) 378 
85+ years 2425.3 (2322.2 - 2531.9) 693 3308.5 (3096.0 - 3531.8) 300 2014.1 (1900.7 - 2132.5) 393 
All Ages 496.6 (490.4 - 502.9) 8,321 557.9 (548.1 - 567.9) 4,283 452.8 (444.5 - 461.1) 4,038 
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All Cancers: Incidence by County of Residence, Maine, 2008-2010 
 Total Male Female 
 AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Androscoggin 510.9 (487.9 - 534.7) 630 593.4 (556.2 - 632.3) 329 454.7 (425.0 – 486.0) 302 
Aroostook 476.7 (451.8 - 502.8) 486 527.7 (489.9 – 568.0) 255 437.7 (404.1 - 473.6) 231 
Cumberland 481.3 (467.5 - 495.4) 1,591 545.4 (523.2 - 568.3) 794 440.6 (422.7 - 459.2) 797 
Franklin 458.3 (419.6 - 499.8) 181 531.7 (470.8 - 598.6) 99 397.0 (347.6 – 452.0) 82 
Hancock 489.9 (460.7 - 520.7) 374 530.6 (486.4 - 578.2) 189 468.3 (428.5 - 511.3) 185 
Kennebec 508.6 (487.8 - 530.1) 779 558.9 (526.8 - 592.6) 395 471.5 (443.9 - 500.4) 384 
Knox 520.4 (485.6 - 557.3) 298 598.5 (544.8 - 656.6) 160 464.2 (418.0 - 514.6) 138 
Lincoln 457.7 (423.6 - 494.2) 245 485.5 (435.2 - 540.7) 123 440.3 (393.5 - 491.9) 122 
Oxford 509.5 (480.0 - 540.4) 389 585.9 (540.1 - 634.7) 213 444.0 (405.8 - 485.1) 176 
Penobscot 529.7 (510.2 - 549.8) 952 610.5 (579.4 - 642.9) 501 469.8 (444.6 - 496.1) 451 
Piscataquis 469.3 (420.4 - 523.1) 123 460.8 (393.3 - 538.3) 61 468.7 (400.1 - 547.2) 62 
Sagadahoc 448.6 (412.6 – 487.0) 201 467.9 (414.1 - 527.1) 98 436.3 (387.7 - 489.8) 103 
Somerset 470.6 (440.6 - 502.2) 317 522.0 (475.7 - 571.9) 165 431.3 (391.9 - 474.1) 152 
Waldo 498.6 (462.5 – 537.0) 252 527.9 (473.2 - 587.5) 123 484.1 (435.2 - 537.4) 129 
Washington 533.7 (495.0 - 574.9) 253 599.1 (540.1 - 663.3) 135 482.2 (430.9 - 538.7) 118 
York 507.7 (491.3 - 524.7) 1,246 578.2 (552.0 - 605.3) 642 458.0 (436.6 - 480.2) 604 
Maine 496.6 (490.4 - 502.9) 8,321 557.9 (548.1 - 567.9) 4,283 452.8 (444.5 - 461.1) 4,038 
 
All Cancers: Incidence by Public Health District of Residence, Maine, 2008-2010 
 Total Male Female 
 AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Aroostook 476.7 (451.8 - 502.8) 486 527.7 (489.9 – 568.0) 255 437.7 (404.1 - 473.6) 231 
Central 496.9 (478.5 - 515.7) 947 566.2 (537.1 - 596.5) 493 447.5 (423.6 - 472.4) 454 
Cumberland 481.3 (467.5 - 495.4) 1,591 545.4 (523.2 - 568.3) 794 440.6 (422.7 - 459.2) 797 
Downeast 506.4 (483.0 - 530.8) 627 557.1 (521.5 - 594.8) 323 472.8 (441.1 - 506.3) 304 
Midcoast 482.9 (465.1 - 501.2) 996 522.5 (495.7 - 550.5) 504 456.2 (432.2 - 481.3) 492 
Penquis 521.5 (503.3 - 540.1) 1,075 589.5 (561.1 – 619.0) 562 469.3 (445.7 – 494.0) 513 
Western 501.9 (485.4 - 518.9) 1,200 579.2 (553.0 - 606.3) 641 442.5 (421.1 - 464.8) 559 
York 507.7 (491.3 - 524.7) 1,246 578.2 (552.0 - 605.3) 642 458.0 (436.6 - 480.2) 604 
Maine 496.6 (490.4 - 502.9) 8,321 557.9 (548.1 - 567.9) 4,283 452.8 (444.5 - 461.1) 4,038 
 
Notes:  
•                County/District rate is significantly higher than Maine rate 
• Incidence case definitions are based on SEER Site Recode ICD-O-3 /WHO 2008 
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. Standard population 
• Abbreviations: AA = Age-adjusted; CI = Confidence Interval; Count/Yr = Average Annual Count 
 
Data Sources: 
• Maine Cancer Registry, 1995-2010 NPCR-CSS submission 
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Lung Cancer: Incidence by Age, Maine 2008-2010 
 
 Total Male Female 
 Rate (95% CI) Count/Yr Rate (95% CI) Count/Yr Rate (95% CI) Count/Yr 
40-44 years 14.5 (10.4 - 19.7) 14 15.2 (9.4 - 23.2) 7 13.9 (8.5 - 21.5) 7 
45-49 years 40.4 (33.8 - 47.9) 44 38.0 (29.1 - 48.9) 20 42.7 (33.4 - 53.9) 24 
50-54 years 79.8 (70.5 - 90.1) 88 80.5 (67.3 - 95.6) 43 79.2 (66.4 - 93.8) 45 
55-59 years 112.9 (101.2 - 125.5) 114 127.1 (109.6 - 146.6) 63 99.3 (84.2 - 116.3) 51 
60-64 years 182.3 (166.2 - 199.6) 157 195.1 (171.6 - 220.9) 83 169.8 (148.2 - 193.8) 74 
65-69 years 332.6 (307.0 - 359.8) 208 375.6 (336.7 - 417.8) 113 292.8 (259.8 - 328.8) 95 
70-74 years 438.1 (404.3 – 474.0) 207 506.8 (454.0 – 564.0) 112 377.8 (335.2 - 424.3) 95 
75-79 years 532.5 (491.4 - 576.0) 207 594.1 (529.4 - 664.6) 102 483.7 (431.8 - 540.2) 105 
80-84 years 512.4 (467.0 – 561.0) 156 651.4 (571.0 - 740.1) 79 421.0 (368.6 - 478.8) 77 
85+ years 322.0 (285.1 - 362.3) 92 517.8 (435.8 - 610.6) 47 230.8 (193.5 - 273.2) 45 




• Incidence case definitions are based on SEER Site Recode ICD-O-3/WHO 2008 
• Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable 
• Rates are calculated per 100,000 population  
• Abbreviations: CI = Confidence Interval; Count/Yr = Average Annual Count 
• “Maine All Ages” includes cases where age is less than 40 years 
 
Data Sources: 
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Lung Cancer: Incidence by County of Residence, Maine 2008-2010 
Lung Cancer: Incidence by Public Health District of Residence, Maine, 2008-2010 
 
Notes:  
•                County/District rate is significantly higher than Maine rate 
• Incidence case definitions are based on SEER Site Recode ICD-O-3 /WHO 2008 
• Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable 
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population 
• Abbreviations: AA = Age-adjusted; CI = Confidence Interval; Count/Yr = Average Annual Count 
 
Data Sources: 
• Maine Cancer Registry, 1995-2010 NPCR-CSS submission 
 
 
 Total Male Female 
 AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Androscoggin 83.8 (74.7 - 93.7) 105 94.3 (80.0 - 110.4) 54 75.6 (63.9 - 88.9) 51 
Aroostook 84.1 (74.1 - 95.1) 89 102.7 (86.6 - 121.2) 50 69.1 (56.9 - 83.6) 39 
Cumberland 68.2 (63.1 - 73.7) 224 82.4 (73.8 - 91.8) 115 58.5 (52.2 - 65.4) 109 
Franklin 69.9 (55.4 - 87.2) 28 90.2 (65.5 - 121.4) 16 57.0 (39.7 - 80.1) 12 
Hancock 67.5 (57.2 - 79.4) 52 74.7 (58.6 - 94.2) 26 63.8 (50.2 - 80.5) 26 
Kennebec 83.7 (75.5 - 92.7) 128 95.0 (81.9 - 109.6) 66 74.9 (64.5 - 86.7) 63 
Knox 70.0 (57.9 - 84.1) 41 88.3 (68.5 - 112.5) 24 56.2 (41.7 – 75.0) 18 
Lincoln 56.0 (45.3 – 69.0) 33 56.3 (41.0 - 76.6) 15 57.3 (42.4 – 77.0) 17 
Oxford 85.6 (74.1 - 98.5) 68 96.1 (78.2 - 117.1) 35 77.7 (63.0 - 95.3) 33 
Penobscot 92.2 (84.3 - 100.8) 167 110.5 (97.5 - 124.8) 90 78.7 (68.8 - 89.7) 77 
Piscataquis 69.4 (51.9 - 91.9) 19 85.3 (57.6 – 124.0) 11 54.0 (34.1 - 84.1) 8 
Sagadahoc 60.5 (47.7 - 75.8) 27 57.8 (40.1 - 81.2) 12 64.2 (46.3 - 87.3) 15 
Somerset 69.2 (58.2 - 81.8) 48 86.1 (68.1 - 107.9) 27 56.5 (43.3 – 73.0) 21 
Waldo 80.9 (67.0 - 97.2) 41 78.5 (58.7 - 103.3) 18 81.7 (63.1 - 104.7) 23 
Washington 90.7 (75.8 – 108.0) 45 98.0 (75.7 - 125.7) 23 84.5 (65.2 - 108.9) 22 
York 72.2 (66.1 - 78.6) 179 81.4 (71.8 – 92.0) 91 65.6 (57.9 - 74.2) 88 
Maine 76.2 (73.8 - 78.7) 1,294 88.1 (84.2 - 92.1) 673 67.5 (64.5 - 70.7) 621 
 Total Male Female 
 AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Aroostook 84.1 (74.1 - 95.1) 89 102.7 (86.6 - 121.2) 50 69.1 (56.9 - 83.6) 39 
Central 78.6 (71.5 - 86.2) 153 90.8 (79.5 - 103.2) 81 69.2 (60.2 - 79.3) 72 
Cumberland 68.2 (63.1 - 73.7) 224 82.4 (73.8 - 91.8) 115 58.5 (52.2 - 65.4) 109 
Downeast 76.5 (67.9 - 86.2) 97 83.8 (70.4 - 99.2) 48 71.8 (60.4 – 85.0) 49 
Midcoast 66.9 (60.6 - 73.8) 142 71.4 (61.8 - 82.1) 69 64.5 (56.0 - 74.1) 72 
Penquis 89.1 (81.8 - 96.9) 186 106.4 (94.6 - 119.4) 101 75.7 (66.7 - 85.8) 85 
Western 82.1 (75.6 - 89.1) 200 93.8 (83.5 – 105.0) 105 73.5 (65.1 - 82.7) 95 
York 72.2 (66.1 - 78.6) 179 81.4 (71.8 – 92.0) 91 65.6 (57.9 - 74.2) 88 
Maine 76.2 (73.8 - 78.7) 1,294 88.1 (84.2 - 92.1) 673 67.5 (64.5 - 70.7) 621 
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Tobacco-related Cancers, Excl. Lung: Incidence by Age, Maine 2008-2010 
 
 Total Male Female 
 Rate (95% CI) Count/Yr Rate (95% CI) Count/Yr Rate (95% CI) Count/Yr 
25-29 years 9.2 (5.6 - 14.2) 7 4.6 (1.5 - 10.8) 2 13.7 (7.7 - 22.5) 5 
30-34 years 13.9 (9.4 - 19.9) 10 9.4 (4.5 - 17.3) 3 18.4 (11.2 - 28.4) 7 
35-39 years 18.6 (13.6 - 24.8) 15 14.7 (8.7 - 23.3) 6 22.3 (14.8 - 32.2) 9 
40-44 years 42.2 (35.0 - 50.5) 40 47.0 (36.2 - 59.9) 22 37.6 (28.3 - 49.1) 18 
45-49 years 61.6 (53.3 - 70.7) 67 79.8 (66.6 - 94.9) 43 43.9 (34.4 - 55.2) 24 
50-54 years 110.1 (99.1 – 122.0) 121 157.3 (138.6 - 177.9) 85 65.0 (53.4 - 78.4) 37 
55-59 years 156.4 (142.7 - 171.2) 158 227.8 (204.1 - 253.5) 112 88.3 (74.2 - 104.4) 46 
60-64 years 224.2 (206.3 - 243.3) 193 322.0 (291.6 - 354.7) 137 128.3 (109.6 - 149.4) 56 
65-69 years 330.0 (304.5 – 357.0) 206 458.7 (415.6 - 505.1) 138 210.6 (182.8 - 241.5) 68 
70-74 years 427.5 (394.2 – 463.0) 202 636.5 (577.2 - 700.2) 141 243.9 (209.9 - 281.8) 61 
75-79 years 507.6 (467.5 - 550.2) 197 786.3 (711.6 - 866.8) 135 287.1 (247.5 - 331.4) 62 
80-84 years 519.0 (473.3 - 567.8) 158 852.9 (760.5 - 953.5) 103 299.4 (255.5 - 348.7) 55 
85+ years 505.1 (458.7 – 555.0) 144 862.9 (756.1 - 980.6) 78 338.5 (293.0 - 389.1) 66 
Maine All Ages  90.5 (87.9 - 93.2) 1,526 131.7 (127.0 - 136.6) 1,009 57.4 (54.5 - 60.4) 517 
 
Notes:  
• Tobacco-related cancers excl. Lung = laryngeal, oral cavity and pharynx, esophageal, stomach, pancreatic, kidney and renal 
pelvis, urinary bladder, cervical cancers, and acute myeloid leukemia.  
• Incidence case definitions are based on SEER Site Recode ICD-O-3/WHO 2008   
• Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable 
• Rates are calculated per 100,000 population . 
• Abbreviations: Excl. = Excluding;  CI = Confidence Interval; Count/Yr = Average Annual Count 
 
Data Sources: 
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Tobacco-related Cancers, Excl. Lung: Incidence by County of Residence, Maine, 2008-2010 
 Total Male Female 
 AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Androscoggin 97.4 (87.5 - 108.1) 121 139.3 (121.7 - 158.9) 77 64.4 (53.7 - 76.8) 44 
Aroostook 92.8 (82.0 - 104.7) 94 128.5 (110.1 - 149.4) 61 64.0 (51.4 - 79.1) 33 
Cumberland 84.9 (79.2 – 91.0) 283 129.8 (119.0 - 141.2) 187 52.1 (46.1 - 58.7) 95 
Franklin 86.0 (69.7 - 105.2) 34 105.2 (79.5 - 137.3) 20 68.6 (48.8 - 94.5) 14 
Hancock 87.5 (75.5 - 101.1) 67 129.7 (108.3 - 154.5) 46 54.8 (41.6 - 71.3) 21 
Kennebec 90.6 (82.0 – 100.0) 139 130.1 (114.8 – 147.0) 91 58.7 (49.1 - 69.6) 47 
Knox 94.8 (80.4 - 111.2) 55 133.4 (108.8 - 162.4) 36 63.6 (47.4 - 84.4) 19 
Lincoln 86.6 (72.2 - 103.4) 46 124.1 (99.3 - 154.1) 31 54.5 (39.2 - 75.1) 16 
Oxford 100.7 (88.0 - 114.9) 78 152.6 (129.8 - 178.6) 55 54.9 (42.3 - 70.5) 22 
Penobscot 91.5 (83.5 - 100.1) 165 135.2 (120.8 - 150.9) 111 55.0 (46.7 - 64.4) 54 
Piscataquis 80.6 (61.3 - 105.1) 21 127.6 (93.5 - 172.3) 17 33.2 (16.9 - 60.9) 4 
Sagadahoc 89.1 (73.5 - 107.3) 40 115.4 (89.3 - 147.1) 24 68.3 (50.0 - 91.7) 16 
Somerset 101.4 (87.7 - 116.8) 68 135.1 (112.1 - 161.7) 42 73.9 (57.7 - 93.6) 25 
Waldo 76.8 (62.8 - 93.2) 38 100.7 (77.4 - 129.2) 23 55.8 (40.1 - 76.2) 15 
Washington 96.4 (80.5 – 115.0) 46 139.5 (112.0 - 172.3) 32 60.9 (43.1 - 84.2) 14 
York 93.1 (86.2 - 100.4) 230 139.2 (126.6 - 152.9) 155 56.2 (49.0 - 64.3) 75 
Maine 90.5 (87.9 - 93.2) 1,526 131.7 (127.0 - 136.6) 1,009 57.4 (54.5 - 60.4) 517 
 
Tobacco-related Cancers, Excl. Lung: Incidence by Public Health District of Residence, Maine, 
2008-2010 
 Total Male Female 
 AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Aroostook 92.8 (82.0 - 104.7) 94 128.5 (110.1 - 149.4) 61 64.0 (51.4 - 79.1) 33 
Central 98.8 (90.7 - 107.4) 189 137.7 (123.6 - 153.1) 120 67.7 (58.6 - 77.9) 69 
Cumberland 84.9 (79.2 – 91.0) 283 129.8 (119.0 - 141.2) 187 52.1 (46.1 - 58.7) 95 
Downeast 90.7 (81.0 - 101.4) 113 133.4 (116.3 - 152.6) 78 56.6 (45.9 - 69.4) 36 
Midcoast 87.1 (79.7 - 95.2) 179 119.0 (106.3 - 132.9) 113 60.7 (52.1 - 70.3) 66 
Penquis 90.1 (82.7 - 98.1) 187 134.1 (120.7 - 148.5) 128 52.3 (44.7 - 60.9) 58 
Western 96.6 (89.5 - 104.2) 233 137.4 (124.9 – 151.0) 153 62.4 (54.5 – 71.0) 80 
York 93.1 (86.2 - 100.4) 230 139.2 (126.6 - 152.9) 155 56.2 (49.0 - 64.3) 75 
Maine 90.5 (87.9 - 93.2) 1,526 131.7 (127.0 - 136.6) 1,009 57.4 (54.5 - 60.4) 517 
 
Notes:  
• Tobacco-related cancers excl. Lung = laryngeal, oral cavity and pharynx, esophageal, stomach, pancreatic, kidney and renal 
pelvis, urinary bladder, cervical cancers, and acute myeloid leukemia  
• Incidence case definitions are based on SEER Site Recode ICD-O-3/WHO 2008 
• Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable 
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population 
• Abbreviations: Excl. = Excluding;  AA = Age-adjusted; CI = Confidence Interval; Count/Yr = Average Annual Count 
 
Data Sources: 
•  Maine Cancer Registry, 1995-2010 NPCR-CSS submission 
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Prostate Cancer: Incidence by Age, Maine 
2008-2010 
 Male 
 Rate (95% CI) Count/Yr 
40-44 years 7.2 (3.5 - 13.3) 3 
45-49 years 36.2 (27.5 - 46.8) 19 
50-54 years 125.7 (109.0 - 144.3) 68 
55-59 years 279.2 (252.9 - 307.5) 138 
60-64 years 515.5 (476.8 - 556.4) 219 
65-69 years 718.0 (663.7 - 775.4) 216 
70-74 years 800.9 (734.2 – 872.0) 177 
75-79 years 656.2 (588.1 - 730.1) 113 
80-84 years 554.8 (480.8 - 637.1) 67 
85+ years 448.0 (372.0 - 534.9) 41 
Maine All Ages 129.3 (124.7 – 134.0) 1,061 
Prostate Cancer: Incidence by County of 
Residence, Maine, 2008-2010 
 
 
Prostate Cancer: Incidence by Public Health 







• Incidence case definitions are based on SEER Site Recode 
ICD-O-3 /WHO 2008 
• Incidence case definitions exclude histologies consistent with 
Kaposi sarcoma and mesothelioma, where applicable 
• Rates are calculated per 100,000 population and age-
adjusted to the year 2000 U.S. standard population 
• Abbreviations: AA = Age-adjusted; CI = Confidence 
Interval; Count/Yr = Average Annual Count 














 AA Rate (95% CI) Count/Yr 
Androscoggin 151.1 (132.9 - 171.1) 86 
Aroostook 106.4 (90.8 - 124.3) 57 
Cumberland 122.1 (112.1 - 132.9) 191 
Franklin 133.3 (105.1 - 167.4) 27 
Hancock 129.6 (109.3 - 153.1) 51 
Kennebec 138.5 (123.2 - 155.3) 103 
Knox 157.2 (131.4 - 187.4) 45 
Lincoln 114.8 (92.5 - 141.9) 32 
Oxford 128.8 (108.8 - 151.7) 51 
Penobscot 129.5 (115.7 - 144.4) 112 
Piscataquis 60.3 (39.7 - 91.3) 9 
Sagadahoc 109.3 (85.7 – 138.0) 26 
Somerset 122.3 (101.4 - 146.7) 42 
Waldo 132.0 (106.3 - 162.5) 34 
Washington 140.2 (113.7 - 171.8) 34 
York 137.7 (125.4 - 150.9) 161 
Maine 129.3 (124.7 – 134.0) 1,061 
 Male 
 AA Rate (95% CI) Count/Yr 
Aroostook 106.4 (90.8 - 124.3) 57 
Central 140.6 (126.6 - 155.7) 128 
Cumberland 122.1 (112.1 - 132.9) 191 
Downeast 134.2 (117.8 - 152.5) 85 
Midcoast 128.7 (116.2 - 142.3) 136 
Penquis 119.8 (107.6 - 133.1) 121 
Western 140.5 (128.1 - 153.8) 164 
York 137.7 (125.4 - 150.9) 161 
Maine 129.3 (124.7 – 134.0) 1,061 
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• Incidence case definitions are based on SEER Site Recode 
ICD-O-3/WHO 2008 
• Incidence case definitions exclude histologies consistent with 
Kaposi sarcoma and mesothelioma, where applicable 
• Rates are calculated per 100,000 population and age-
adjusted to the year 2000 U.S. standard population 
• Abbreviations: AA = Age-adjusted; CI = Confidence Interval; 
Count/Yr = Average Annual Count 










Female Breast Cancer: Incidence by County 
of Residence, Maine, 2008-2010 
 
Female Breast Cancer: Incidence by Public 
Health District of Residence, Maine, 2008-
2010 
 Female 
 AA Rate (95% CI) Count/Yr 
Aroostook 98.9 (83.2 - 117.1) 51 
Central 109.8 (98.1 - 122.6) 110 
Cumberland 132.6 (122.8 - 142.9) 241 
Downeast 125.2 (109.1 - 143.2) 79 
Midcoast 120.4 (108.2 - 133.8) 128 
Penquis 132.0 (119.5 - 145.5) 143 
Western 114.6 (103.8 - 126.2) 144 
York 129.3 (118.1 - 141.3) 171 





 Rate (95% CI) Count/Yr 
25-29 years 10.0 (5.0 - 17.9) 4 
30-34 years 29.4 (20.1 - 41.6) 11 
35-39 years 58.9 (46.3 – 74.0) 25 
40-44 years 121.3 (103.9 – 140.7) 58 
45-49 years 181.7 (161.8 – 203.4) 101 
50-54 years 209.2 (188.0 - 232.2) 118 
55-59 years 268.2 (243.0 - 295.3) 139 
60-64 years 350.5 (319.0 - 384.1) 152 
65-69 years 442.8 (402.0 - 486.6) 144 
70-74 years 422.8 (377.7 - 471.9) 106 
75-79 years 465.3 (414.4 - 520.7) 101 
80-84 years 406.5 (355.0 - 463.3) 75 
85+ years 369.3 (321.7 – 422.0) 72 
Maine All Ages 124.5 (120.2 - 128.9) 1,105 
 Female 
 AA Rate (95% CI) Count/Yr 
Androscoggin 111.6 (97.1 - 127.7) 73 
Aroostook 98.9 (83.2 - 117.1) 51 
Cumberland 132.6 (122.8 - 142.9) 241 
Franklin 117.0 (91.0 - 148.8) 24 
Hancock 123.0 (103.2 - 145.9) 49 
Kennebec 136.0 (121.4 - 152.1) 110 
Knox 123.5 (99.9 - 151.6) 35 
Lincoln 112.3 (89.8 - 139.9) 32 
Oxford 118.5 (99.3 - 140.7) 47 
Penobscot 131.8 (118.5 - 146.2) 125 
Piscataquis 134.1 (98.4 - 180.2) 18 
Sagadahoc 110.2 (86.3 – 139.0) 26 
Somerset 105.0 (86.1 - 127.2) 37 
Waldo 133.6 (108.3 - 163.5) 35 
Washington 128.9 (102.4 - 160.9) 30 
York 129.3 (118.1 - 141.3) 171 
Maine 124.5 (120.2 - 128.9) 1,105 
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Colorectal Cancer: Incidence by Age, Maine, 2008-2010 
 
 Total Male Female 
 Rate (95% CI) Count/Yr Rate (95% CI) Count/Yr Rate (95% CI) Count/Yr 
35-39 years 12.5 (8.5 - 17.8) 10 11.5 (6.3 - 19.2) 5 13.5 (7.9 - 21.7) 6 
40-44 years 16.7 (12.3 - 22.2) 16 15.9 (10.0 - 24.1) 7 17.4 (11.3 - 25.7) 8 
45-49 years 28.5 (23.0 - 34.9) 31 30.6 (22.6 - 40.4) 16 26.5 (19.2 - 35.5) 15 
50-54 years 49.0 (41.7 - 57.1) 54 60.1 (48.7 - 73.3) 32 38.4 (29.6 – 40.9) 22 
55-59 years 68.3 (59.3 - 78.3) 69 77.1 (63.6 - 92.6) 38 60.0 (48.4 - 73.5) 31 
60-64 years 84.6 (73.7 - 96.6) 73 108.1 (90.8 - 127.7) 46 61.5 (48.8 - 76.5) 27 
65-69 years 134.3 (118.3 – 152.0) 84 166.2 (140.7 – 195.0) 50 104.8 (85.4 - 127.2) 34 
70-74 years 184.8 (163.1 - 208.6) 87 197.6 (165.2 - 234.5) 44 173.6 (145.2 – 206.0) 44 
75-79 years 270.1 (241.1 - 301.6) 105 326.2 (278.7 - 379.4) 56 225.7 (190.7 - 265.3) 49 
80-84 years 278.1 (244.9 - 314.5) 85 306.4 (252.1 – 369.0) 37 259.5 (218.7 - 305.7) 48 
85+ years 361.6 (322.5 - 404.2) 103 370.9 (302.1 - 450.6) 34 357.3 (310.5 - 409.2) 70 




• Incidence case definitions are based on SEER Site Recode ICD-O-3/WHO 2008 
• Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable 
• Rates are calculated per 100,000 population  
• Abbreviations: CI = Confidence Interval; Count/Yr = Average Annual Count 
• “Maine All Ages” includes cases where age is less than 35 years 
 
Data Sources: 
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Colorectal Cancer: Incidence by County of Residence, Maine, 2008-2010 
 Total Male Female 
 AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Androscoggin 42.0 (35.6 - 49.2) 52 53.5 (42.5 - 66.5) 28 35.2 (27.5 - 44.6) 24 
Aroostook 52.5 (44.7 - 61.5) 55 59.3 (47.1 – 74.0) 29 45.6 (35.8 - 57.7) 27 
Cumberland 40.5 (36.5 - 44.8) 132 46.2 (39.8 - 53.3) 65 35.9 (30.9 - 41.4) 67 
Franklin 46.2 (34.3 - 61.2) 18 45.6 (28.5 - 69.5) 8 45.5 (30.2 - 66.7) 10 
Hancock 46.0 (37.5 - 56.1) 36 52.6 (39.2 - 69.6) 18 40.4 (29.9 – 54.0) 17 
Kennebec 42.5 (36.7 - 49.1) 65 44.2 (35.5 - 54.6) 31 41.3 (33.5 - 50.6) 34 
Knox 32.8 (24.9 - 42.9) 20 36.2 (24.2 - 52.9) 10 28.6 (19.0 - 42.5) 10 
Lincoln 36.4 (27.6 - 47.6) 20 39.4 (26.2 – 58.0) 10 33.7 (22.7 - 49.8) 10 
Oxford 41.4 (33.4 - 50.9) 32 50.3 (37.3 - 66.6) 17 33.4 (24.0 - 45.7) 14 
Penobscot 46.7 (41.0 - 52.9) 84 57.0 (47.8 - 67.6) 47 38.8 (31.8 - 46.9) 38 
Piscataquis 44.6 (31.0 - 63.5) 12 38.3 (20.6 - 67.6) 5 46.6 (28.7 - 74.7) 7 
Sagadahoc 33.8 (24.7 - 45.5) 16 35.4 (21.5 - 55.3) 7 33.2 (21.5 - 49.9) 9 
Somerset 38.3 (30.0 - 48.4) 25 36.2 (24.5 - 51.9) 11 40.2 (28.8 - 54.9) 14 
Waldo 48.4 (37.8 - 61.3) 25 69.2 (50.4 - 93.2) 16 31.2 (20.3 - 46.9) 9 
Washington 50.6 (39.5 - 64.3) 25 55.7 (39.2 - 77.7) 13 44.9 (30.8 - 64.4) 12 
York 44.5 (39.7 - 49.7) 108 48.8 (41.4 - 57.1) 54 39.9 (33.9 - 46.9) 54 
Maine 43.1 (41.3 – 45.0) 724 48.7 (45.8 - 51.8) 368 38.2 (35.9 - 40.6) 356 
 
Colorectal Cancer: Incidence by Public Health District of Residence, Maine, 2008-2010 
 Total Male Female 
 AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Aroostook 52.5 (44.7 - 61.5) 55 59.3 (47.1 – 74.0) 29 45.6 (35.8 - 57.7) 27 
Central 40.4 (35.3 - 46.1) 77 46.9 (38.6 - 56.5) 39 36.7 (30.2 - 44.2) 38 
Cumberland 40.5 (36.5 - 44.8) 132 46.2 (39.8 - 53.3) 65 35.9 (30.9 - 41.4) 67 
Downeast 47.7 (40.8 - 55.5) 61 53.9 (43.2 - 66.7) 31 41.8 (33.3 - 52.3) 29 
Midcoast 37.7 (33.0 – 43.0) 81 44.6 (37.1 - 53.4) 43 31.5 (25.8 - 38.2) 38 
Penquis 46.3 (41.1 - 52.1) 96 54.3 (45.9 - 63.8) 52 39.8 (33.3 - 47.4) 45 
Western 42.3 (37.6 - 47.4) 102 50.8 (43.1 - 59.6) 53 36.2 (30.4 - 42.8) 48 
York 44.5 (39.7 - 49.7) 108 48.8 (41.4 - 57.1) 54 39.9 (33.9 - 46.9) 54 
Maine 43.1 (41.3 – 45.0) 724 48.7 (45.8 - 51.8) 368 38.2 (35.9 - 40.6) 356 
 
Notes:  
• Incidence case definitions are based on SEER Site Recode ICD-O-3/WHO 2008 
• Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable 
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population 
• Abbreviations: AA = Age-adjusted; CI = Confidence Interval; Count/Yr = Average Annual Count 
 
Data Sources: 
• Maine Cancer Registry, 1995-2010 NPCR-CSS submission 
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Brain and Other Nervous System Tumors: Incidence by County of Residence, Maine, 2006-2010 
 All Behaviors Malignant Non-Malignant 
 AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Androscoggin 15.2 (12.1 - 18.7) 18 6.4 (4.4 - 8.9) 7 8.8 (6.5 - 11.5) 11 
Aroostook 15.1 (11.6 - 19.4) 14 7.4 (5.0 - 10.6) 7 7.7 (5.2 – 11.0) 7 
Cumberland 14.4 (12.6 - 16.5) 45 8.3 (6.9 - 9.9) 25 6.2 (5.0 - 7.6) 19 
Franklin 9.7 (5.5 – 16.0) 3 4.3 (1.8 – 9.0) 2 5.4 (2.4 - 10.6) 2 
Hancock 14.3 (10.4 - 19.2) 10 7.8 (5.0 - 11.8) 5 6.4 (4.0 - 9.9) 5 
Kennebec 15.8 (12.9 - 19.1) 23 8.0 (5.9 - 10.5) 11 7.8 (5.9 - 10.2) 12 
Knox 19.2 (14.2 - 25.5) 11 9.6 (6.2 - 14.4) 5 9.6 (6.1 - 14.4) 5 
Lincoln 12.8 (8.2 - 19.2) 6 6.6 (3.4 - 11.7) 3 6.1 (3.2 - 10.9) 3 
Oxford 14.5 (10.5 - 19.5) 10 6.7 (4.1 - 10.3) 5 7.8 (5.0 - 11.8) 5 
Penobscot 17.8 (15.0 – 21.0) 29 8.6 (6.7 - 10.9) 14 9.2 (7.2 - 11.6) 15 
Piscataquis 25.9 (16.0 - 39.6) 5 11.8 (6.0 - 21.3) 3 14.1 (6.8 - 25.6) 2 
Sagadahoc 14.8 (9.7 - 21.6) 6 6.7 (3.5 - 11.5) 3 8.1 (4.4 - 13.6) 3 
Somerset 12.8 (9.1 - 17.7) 8 5.9 (3.5 - 9.5) 4 6.9 (4.3 - 10.7) 4 
Waldo 18.7 (13.4 - 25.5) 9 9.0 (5.4 – 14.0) 4 9.8 (6.1 – 15.0) 5 
Washington 11.1 (6.8 - 17.2) 5 5.9 (2.9 - 10.7) 2 5.2 (2.5 - 9.8) 2 
York 15.9 (13.6 - 18.5) 36 7.8 (6.2 - 9.7) 17 8.1 (6.5 – 10.0) 19 
Maine 15.3 (14.4 - 16.3) 235 7.7 (7.1 - 8.4) 117 7.6 (7.0 - 8.3) 118 
Brain and Other Nervous System Tumors: Incidence by Public Health District of Residence, 
Maine, 2006-2010 
 All Behaviors Malignant Non-Malignant 
 
AA Rate (95% CI) Count/Yr 
AA Rate 
 (95% CI) 
Count/Yr 
AA Rate  
(95% CI) 
Count/Yr 
Aroostook 15.1 (11.6 - 19.4) 14 7.4 (5.0 - 10.6) 7 7.7 (5.2 – 11.0) 7 
Central 14.4 (12.0 - 17.2) 26 6.3 (4.7 - 8.3) 11 8.1 (6.4 - 10.2) 15 
Cumberland 14.4 (12.6 - 16.5) 45 8.3 (6.9 - 9.9) 25 6.2 (5.0 - 7.6) 19 
Downeast 13.0 (10.0 - 16.6) 14 7.0 (4.9 - 9.9) 8 6.0 (4.1 - 8.5) 7 
Midcoast 16.5 (13.9 - 19.5) 31 8.0 (6.2 - 10.1) 15 8.5 (6.6 - 10.8) 16 
Penquis 18.5 (15.7 - 21.6) 34 9.0 (7.2 - 11.2) 17 9.4 (7.5 - 11.8) 17 
Western 14.1 (11.9 - 16.6) 31 6.2 (4.8 – 8.0) 13 7.9 (6.3 - 9.8) 17 
York 15.9 (13.6 - 18.5) 36 7.8 (6.2 - 9.7) 17 8.1 (6.5 – 10.0) 19 
Maine 15.3 (14.4 - 16.3) 235 7.7 (7.1 - 8.4) 117 7.6 (7.0 - 8.3) 118 
 
Notes:  
• Incidence case definitions are based on SEER Site Recode ICD-O-3/WHO 2008   
• Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable 
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population 
• Abbreviations: AA = Age-adjusted; CI = Confidence Interval; Count/Yr = Average Annual Count 
 
Data Sources: 
• Maine Cancer Registry, 1995-2010 NPCR-CSS submission 
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Age-adjusted Obesity-related Cancer Incidence Rates, Maine and US, 2010 
 Total 
 AA Rate (95% CI) Count SEER Whites SEER All races 
Adenocarcinoma of the Esophagus 5.7 (4.6 – 7.0) 102 3.1 (2.8 - 3.3) 2.6 (2.4 - 2.8) 
Colorectal Cancer 39.6 (36.6 - 42.9) 666 39.2 (38.4 – 40.0) 40.6 (39.9 - 41.3) 
Kidney and Renal Pelvis Cancer 14.2 (12.4 - 16.2) 238 14.7 (14.2 - 15.2) 14.8 (14.3 - 15.2) 
Cancer of Pancreas 13.6 (11.9 - 15.5) 234 11.9 (11.5 - 12.4) 12.4 (12.0 - 12.8) 
Endometrial Cancer  See gender specific rate below 
Post menopausal Breast Cancer See gender specific rate below 
 
Age-adjusted Obesity-related Cancer Incidence Rates among Males, Maine and US, 2010 
 Male 
 AA Rate (95% CI) Count SEER Whites SEER All races 
Adenocarcinoma of the Esophagus 11.3 (9.1 – 14.0) 93 5.7 (5.3 - 6.2) 4.9 (4.5 - 5.3) 
Colorectal Cancer 46.0 (41.2 - 51.2) 352 45.1 (43.8 - 46.4) 46.6 (45.5 - 47.8) 
Kidney and Renal Pelvis Cancer 20.2 (17.1 - 23.7) 159 20.2 (19.4 - 21.1) 20.6 (19.8 - 21.4) 
Cancer of Pancreas 14.7 (12.1 - 17.8) 115 13.3 (12.6 – 14.0) 13.7 (13.1 - 14.3) 
 
Age-adjusted Obesity-related Cancer Incidence Rates among Females, Maine and US, 2010 
 Female 
 AA Rate (95% CI) Count SEER Whites SEER All races 
Adenocarcinoma of the Esophagus 0.9 (0.4 - 1.9) 9 0.8 (0.6 – 1.0) 0.7 (0.6 - 0.8) 
Colorectal Cancer 32.3 (28.7 - 36.4) 297 34.3 (33.3 - 35.3) 35.7 (34.8 - 36.6) 
Kidney and Renal Pelvis Cancer 9.1 (7.1 - 11.5) 79 9.9 (9.4 - 10.5) 9.8 (9.3 - 10.3) 
Cancer of Pancreas 12.8 (10.5 - 15.4) 119 10.8 (10.2 - 11.4) 11.3 (10.8 - 11.8) 
Post menopausal Breast Cancer 32.3 (28.7 - 36.4) 297 27.8 (26.9 - 28.7) 27.3 (26.5 - 28.1) 
Endometrial Cancer  344.5 (322.5 - 367.7) 927 352.4 (346.3 - 358.6) 341.3 (336.0 - 346.7) 
 
Notes:  
•                Maine rate is significantly higher than SEER White rate 
• Obesity-related Cancers = Adenocarcinoma of the Esophagus, cancers of Colon and Rectum, Pancreas, Kidney and Renal Pelvis,  
Endometrium (Corpus Uteri), and Postmenopausal Breast Cancer. Postmenopausal Breast Cancer include malignant breast cancer 
cases diagnosed among females with age 50 years or greater  
• Incidence case definitions are based on SEER Site Recode ICD-O-3/WHO 2008  
• Incidence case definitions exclude histologies consistent with Kaposi sarcoma and mesothelioma, where applicable 
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population 
• Abbreviations: AA = Age-adjusted; CI = Confidence Interval; SEER = Surveillance, Epidemiology, and End Results; Count/Yr = 
Average Annual Count 
 
Data Sources: 
• Maine Cancer Registry, 1995-2010 NPCR-CSS submission 
• National Incidence: Surveillance, Epidemiology and End Results, SEER 9  Research Data, Nov 2012 Sub (1973-2010) 
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Age-adjusted Incidence of all Malignant Cancers, Maine 1995-2010 
   
Cancer Incidence Rates: All Malignant Cancers, Maine 1995-2010 Maine  
Year 
Total Male Female 
AA Rate (95% CI) AA Rate AA Rate 
1995 480.1 (468.3 - 492.1) 561.9 (542.3 - 582.1) 430.7 (415.5 - 446.4) 
1996 493.4 (481.6 - 505.6) 585.3 (565.4 - 605.8) 436.5 (421.3 - 452.0) 
1997 509.4 (497.4 - 521.6) 608.9 (588.7 - 629.5) 444.7 (429.6 - 460.2) 
1998 516.8 (504.8 - 528.9) 616.9 (596.8 - 637.5) 452.4 (437.2 - 468.0) 
1999 509.6 (497.8 - 521.5) 615.1 (595.3 - 635.4) 440.3 (425.5 - 455.5) 
2000 529.4 (517.5 - 541.4) 624.8 (605.1 - 644.9) 463.5 (448.4 - 478.9) 
2001 540.4 (528.5 - 552.6) 649.4 (629.5 - 669.7) 466.8 (451.7 - 482.2) 
2002 533.4 (521.6 - 545.3) 632.7 (613.3 - 652.5) 465.6 (450.7 - 480.9) 
2003 526.8 (515.3 - 538.6) 626.8 (607.7 - 646.3) 456.5 (441.8 - 471.6) 
2004 542.6 (531.0 - 554.5) 637.0 (618.1 - 656.5) 471.6 (456.8 - 486.8) 
2005 532.6 (521.1 - 544.3) 611.8 (593.2 - 630.7) 477.7 (462.9 - 493.0) 
2006 543.2 (531.7 - 554.9) 629.2 (610.6 - 648.2) 482.1 (467.3 - 497.4) 
2007 525.3 (514.0 - 536.7) 610.1 (592.0 - 628.6) 464.2 (449.7 - 479.1) 
2008 509.7 (498.7 - 520.9) 578.8 (561.4 - 596.7) 459.3 (444.9 - 474.0) 
2009 494.2 (483.4 - 505.2) 552.0 (535.1 - 569.4) 452.7 (438.5 - 467.3) 
2010 486.7 (476.1 - 497.6) 543.9 (527.3 – 561.0) 446.9 (432.7 - 461.4) 
 
Notes:  
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population 
Data Sources: 
• Maine Incidence: Maine Cancer Registry, 1995-2010 NPCR-CSS submission 
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Age-adjusted Incidence of Colorectal Cancer, Maine 1995-2010 
 
Age-adjusted Incidence of Prostate Cancer, Maine 1995-2010 
 
Data Sources: 
• Data Source: Maine Incidence: Maine Cancer Registry, 1995-2010 NPCR-CSS submission 
Notes:  














































































































































































Age-adjusted Incidence of Breast Cancer among Females, Maine 1995-2010 
 



















• Data Source: Maine Incidence: Maine Cancer Registry, 1995-2010 NPCR-CSS submission 
Notes:  
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MO R TA L I T Y :  S TAT E  A N D  N AT I O N A L  C O M PA R I S O N S  
Age-adjusted Cancer Mortality Rate by Site, Maine 2010 
 
Total 
AA Rate (95% CI) Count US Whites US All Races 
All Malignant Cancers 186.6 (180.2 - 193.3) 3,247 171.4 (170.9 - 171.8) 171.8 (171.3 - 172.2) 
Lung and Bronchus 55.1 (51.6 - 58.8) 957 48.1 (47.9 - 48.4) 47.4 (47.2 - 47.7) 
Tobacco-related, excl. Lung 37.3 (34.4 - 40.3) 646 34.4 (34.2 - 34.6) 34.6 (34.4 - 34.8) 
Colon and Rectum 16.4 (14.5 - 18.4) 290 15.0 (14.9 - 15.2) 15.5 (15.4 - 15.6) 
Breast See page 28 for gender specific rates 
Prostate See page 29 for gender specific rates 
Pancreas 11.6 (10.0 - 13.4) 198 10.9 (10.8 - 11.0) 11.0 (10.9 - 11.1) 
Leukemia 7.5 (6.2 - 9.0) 125 7.2 (7.1 - 7.3) 6.9 (6.8 - 7.0) 
Esophagus 6.3 (5.2 - 7.6) 112 4.4 (4.3 - 4.5) 4.3 (4.2 - 4.3) 
Liver & Intrahep. Bile Duct 6.0 (4.9 - 7.4) 108 5.5 (5.4 - 5.6) 5.9 (5.8 - 6.0) 
Urinary Bladder 6.1 (5.0 - 7.5) 106 4.6 (4.6 - 4.7) 4.4 (4.4 - 4.5) 
Non-Hodgkin Lymphoma 6.1 (4.9 - 7.4) 103 6.4 (6.3 - 6.5) 6.1 (6.1 - 6.2) 
Brain and Other Nervous System 5.0 (4.0 - 6.2) 85 4.6 (4.5 - 4.7) 4.2 (4.2 - 4.3) 
Myeloma 3.8 (3.0 - 4.9) 68 3.1 (3.0 - 3.1) 3.3 (3.3 - 3.4) 
Kidney and Renal Pelvis 3.4 (2.6 - 4.4) 60 4.0 (4.0 - 4.1) 3.9 (3.9 - 4.0) 
Acute Myeloid Leukemia 3.6 (2.7 - 4.7) 58 2.9 (2.8 - 3.0) 2.8 (2.7 - 2.9) 
Melanoma of the Skin 3.1 (2.3 - 4.0) 54 3.2 (3.1 - 3.2) 2.7 (2.7 - 2.8) 
Oral Cavity and Pharynx 2.3 (1.6 - 3.1) 41 2.4 (2.4 - 2.5) 2.5 (2.4 - 2.5) 
Stomach 2.2 (1.6 - 3.0) 39 3.0 (2.9 - 3.1) 3.4 (3.4 - 3.5) 
Larynx 1.1 (0.6 - 1.7) 19 1.0 (1.0 - 1.1) 1.1 (1.0 - 1.1) 
Thyroid ~ ~ 0.5 (0.5 - 0.5) 0.5 (0.5 - 0.5) 
Hodgkin Lymphoma ~ ~ 0.4 (0.4 - 0.4) 0.4 (0.4 - 0.4) 
Ovary See page 29 for gender specific rates 
Corpus Uteri See page 29 for gender specific rates 
Cervix Uteri See page 29 for gender specific rates 
Testis See page 28 for gender specific rates 
 
Notes:  
•                Maine rate is significantly higher than US White rate 
• Mortality case definitions are based on ICD-10 codes (See page 3) 
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population 
• Abbreviations: AA = Age-adjusted; CI = Confidence Interval; Excl. = Excluding; Intrahep.= Intrahepatic 
• Tobacco-related cancers, excl. lung = laryngeal, oral cavity and pharynx, esophageal, stomach, pancreatic, kidney and renal 
pelvis, urinary bladder,  cervical cancers, and acute myeloid leukemia 
• ~ Rates and counts are suppressed due to fewer than 10 cases 
 
Data Sources: 
• Maine and U.S. Mortality: National Center for Health Statistics, All Causes of Death, Public-Use with State, Total U.S. (1969-2010) 
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AA Rate (95% CI) Count US Whites US All Races 
All Malignant Cancers 226.0 (215.2 - 237.3) 1,717 207.1 (206.3 - 207.9) 208.8 (208.0 - 209.6) 
Lung and Bronchus 66.1 (60.4 - 72.3) 513 59.9 (59.5 - 60.4) 60.1 (59.7 - 60.5) 
Tobacco-related, excl. Lung 53.6 (48.4 - 59.2) 413 47.8 (47.4 - 48.2) 47.7 (47.3 - 48.0) 
Colon and Rectum 20.9 (17.7 - 24.6) 158 18.1 (17.9 - 18.4) 18.7 (18.5 - 19.0) 
Prostate 21.0 (17.6 - 24.7) 144 20.1 (19.8 - 20.4) 21.8 (21.6 - 22.1) 
Pancreas 12.8 (10.4 - 15.7) 98 12.6 (12.4 - 12.8) 12.7 (12.5 - 12.9) 
Esophagus 11.1 (8.8 - 13.7) 89 7.8 (7.6 - 8.0) 7.5 (7.4 - 7.7) 
Urinary Bladder 11.6 (9.2 - 14.4) 84 8.1 (8.0 - 8.3) 7.7 (7.6 - 7.9) 
Leukemia 11.3 (9.0 - 14.1) 83 9.6 (9.4 - 9.8) 9.3 (9.1 - 9.4) 
Liver & Intrahep. Bile Duct 8.9 (6.9 - 11.3) 72 8.0 (7.8 - 8.2) 8.7 (8.6 - 8.9) 
Non-Hodgkin Lymphoma 7.4 (5.5 - 9.8) 53 8.1 (8.0 - 8.3) 7.8 (7.7 - 8.0) 
Brain and Other Nervous System 6.1 (4.4 - 8.2) 47 5.6 (5.5 - 5.8) 5.2 (5.1 - 5.3) 
Kidney and Renal Pelvis 5.5 (3.9 - 7.6) 41 5.9 (5.7 - 6.0) 5.7 (5.6 - 5.8) 
Melanoma of the Skin 4.9 (3.4 - 6.8) 38 4.7 (4.6 - 4.8) 4.1 (4.0 - 4.2) 
Acute Myeloid Leukemia 4.9 (3.4 - 6.8) 36 3.8 (3.7 - 3.9) 3.6 (3.5 - 3.7) 
Myeloma 3.9 (2.6 - 5.6) 30 3.9 (3.8 - 4.0) 4.2 (4.1 - 4.3) 
Oral Cavity and Pharynx 2.9 (1.9 - 4.4) 25 3.7 (3.6 - 3.8) 3.8 (3.7 - 3.9) 
Stomach 2.8 (1.8 - 4.4) 23 4.0 (3.9 - 4.1) 4.6 (4.5 - 4.8) 
Larynx 2.0 (1.1 - 3.3) 17 1.9 (1.8 - 1.9) 1.9 (1.9 - 2.0) 
Thyroid ~ ~ 0.5 (0.5 - 0.6) 0.5 (0.5 - 0.5) 
Hodgkin Lymphoma ~ ~ 0.5 (0.5 - 0.6) 0.5 (0.5 - 0.5) 
Testis ~ ~ 0.3 (0.3 - 0.3) 0.3 (0.2 - 0.3) 
Breast ~ ~ 0.3 (0.3 - 0.3) 0.3 (0.3 - 0.3) 
 
Notes:  
•                Maine rate is significantly higher than US White rate 
• Mortality case definitions are based on ICD-10 codes (See page 3) 
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population 
• Abbreviations: AA = Age-adjusted; CI = Confidence Interval; Excl. = Excluding; Intrahep.= Intrahepatic 
• Tobacco-related cancers, excl. lung = laryngeal, oral cavity and pharynx, esophageal, stomach, pancreatic, kidney and renal 
pelvis, urinary bladder, cervical cancers, and acute myeloid leukemia 
• ~ Rates and counts are suppressed due to fewer than 10 cases 
 
Data Sources: 
• Maine and U.S. Mortality: National Center for Health Statistics, All Causes of Death, Public-Use with State, Total U.S. (1969-2010) 
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Age-adjusted Cancer Mortality Rates by Site, Maine 2010 

Female 
AA Rate (95% CI) Count US Whites US All Races 
All Malignant Cancers 158.5 (150.5 - 166.9) 1,530 145.9 (145.3 - 146.5) 145.7 (145.2 - 146.3) 
Lung and Bronchus 47.0 (42.7 - 51.7) 444 39.2 (38.9 - 39.5) 37.9 (37.7 - 38.2) 
Tobacco-related, excl. Lung 24.3 (21.2 - 27.8) 233 24.1 (23.9 - 24.4) 24.6 (24.4 - 24.9) 
Breast 20.1 (17.3 - 23.2) 195 21.3 (21.1 - 21.6) 21.9 (21.7 - 22.1) 
Colon and Rectum 13.1 (10.9 - 15.6) 132 12.6 (12.4 - 12.8) 13.0 (12.8 - 13.2) 
Pancreas 10.4 (8.4 - 12.7) 100 9.4 (9.3 - 9.6) 9.6 (9.4 - 9.7) 
Ovary 9.1 (7.3 - 11.3) 90 8.1 (8.0 - 8.3) 7.8 (7.7 - 7.9) 
Non-Hodgkin Lymphoma 5.0 (3.7 - 6.7) 50 5.0 (4.9 - 5.1) 4.9 (4.8 - 5.0) 
Leukemia 4.6 (3.3 - 6.4) 42 5.4 (5.2 - 5.5) 5.2 (5.1 - 5.3) 
Brain and Other Nervous System 4.1 (2.9 - 5.8) 38 3.7 (3.6 - 3.8) 3.4 (3.3 - 3.5) 
Myeloma 3.8 (2.7 - 5.3) 38 2.4 (2.4 - 2.5) 2.7 (2.6 - 2.8) 
Liver & Intrahep. Bile Duct 3.8 (2.6 - 5.3) 36 3.3 (3.2 - 3.4) 3.3 (3.2 - 3.4) 
Corpus Uteri 2.5 (1.7 - 3.8) 26 1.8 (1.8 - 1.9) 1.9 (1.9 - 2.0) 
Esophagus 2.3 (1.4 - 3.5) 23 1.6 (1.5 - 1.7) 1.6 (1.6 - 1.7) 
Acute Myeloid Leukemia 2.6 (1.6 - 4.1) 22 2.2 (2.2 - 2.3) 2.2 (2.1 - 2.2) 
Urinary Bladder 2.2 (1.3 - 3.4) 22 2.2 (2.1 - 2.3) 2.2 (2.1 - 2.3) 
Kidney and Renal Pelvis 2.0 (1.2 - 3.2) 19 2.6 (2.5 - 2.7) 2.5 (2.4 - 2.6) 
Melanoma of the Skin 1.8 (1.0 - 3.0) 16 2.0 (1.9 - 2.0) 1.7 (1.6 - 1.8) 
Oral Cavity and Pharynx 1.7 (0.9 - 2.8) 16 1.4 (1.3 - 1.5) 1.4 (1.3 - 1.5) 
Stomach 1.6 (0.9 - 2.7) 16 2.2 (2.1 - 2.3) 2.5 (2.4 - 2.6) 
Cervix Uteri 1.4 (0.7 - 2.5) 13 2.1 (2.0 - 2.2) 2.3 (2.2 - 2.3) 
Thyroid ~ ~ 0.5 (0.5 - 0.5) 0.5 (0.5 - 0.5) 
Hodgkin Lymphoma ~ ~ 0.3 (0.3 - 0.3) 0.3 (0.3 - 0.3) 
Larynx ~ ~ 0.4 (0.3 - 0.4) 0.4 (0.4 - 0.4) 
 
Notes:  
•                Maine rate is significantly higher than US White rate 
• Mortality case definitions are based on ICD-10 codes (See page 3) 
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population 
• Abbreviations: AA = Age-adjusted; CI = Confidence Interval; Excl. = Excluding; Intrahep.= Intrahepatic 
• Tobacco-related cancers, excl. lung = laryngeal, oral cavity and pharynx, esophageal, stomach, pancreatic, kidney and renal 
pelvis, urinary bladder, cervical cancers, and acute myeloid leukemia 
• ~ Rates and counts are suppressed due to fewer than 10 cases 
 
Data Sources: 
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All Cancers: Mortali ty by County of Residence, Maine 2006-2010 
 
Total Male Female 
AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Androscoggin 193.3 (182.5 - 204.7) 241 239.1 (220.4 - 258.9) 126 162.8 (149.6 - 177.0) 115 
Aroostook 193.8 (181.9 - 206.4) 203 235.2 (215.3 - 256.7) 107 164.9 (150.1 - 181.0) 96 
Cumberland 176.9 (170.5 - 183.6) 581 223.5 (212.1 - 235.3) 300 147.8 (140.0 - 156.0) 282 
Franklin 192.6 (173.1 - 213.8) 74 236.5 (203.6 - 273.3) 40 163.6 (139.5 - 191.0) 34 
Hancock 179.7 (166.4 - 194.0) 137 214.2 (191.9 - 238.4) 71 159.1 (142.1 - 177.8) 67 
Kennebec 204.2 (194.0 - 214.9) 306 245.6 (228.6 - 263.5) 160 175.5 (162.8 - 189.1) 146 
Knox 171.9 (157.2 - 187.8) 104 219.6 (194.7 - 247.2) 58 136.9 (119.2 - 156.9) 46 
Lincoln 168.1 (152.9 - 184.7) 94 203.6 (178.5 - 231.6) 49 143.9 (124.9 - 165.6) 44 
Oxford 203.6 (189.5 - 218.7) 157 251.4 (227.7 - 277.0) 86 169.4 (152.0 - 188.5) 71 
Penobscot 193.9 (184.7 - 203.4) 342 238.9 (223.4 - 255.3) 183 162.0 (150.8 - 173.8) 160 
Piscataquis 201.1 (177.1 - 227.9) 53 248.8 (208.9 - 294.9) 30 163.0 (134.5 - 197.1) 24 
Sagadahoc 182.9 (165.2 - 202.1) 81 221.2 (191.3 - 254.5) 42 158.9 (137.0 - 183.7) 39 
Somerset 201.7 (186.6 - 217.9) 134 242.2 (217.0 - 269.6) 71 171.6 (153.0 - 192.2) 63 
Waldo 186.6 (169.5 - 205.0) 91 220.0 (191.6 - 251.6) 46 164.8 (143.5 - 188.6) 45 
Washington 209.3 (191.1 - 228.9) 101 267.8 (236.8 - 302.1) 57 167.9 (145.9 - 192.7) 44 
York 180.4 (172.9 - 188.3) 436 221.9 (209.0 - 235.4) 230 152.4 (143.1 - 162.2) 207 
Maine 187.7 (184.8 - 190.7) 3,135 231.1 (226.1 - 236.2) 1,653 158.3 (154.7 - 162.0) 1,481 
 
All Cancers: Mortality by Public Health District of Residence, Maine 2006-2010 

Total Male Female 
AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Aroostook 193.8 (181.9 - 206.4) 203 235.2 (215.3 - 256.7) 107 164.9 (150.1 - 181.0) 96 
Central 203.3 (194.8 - 212.0) 441 244.4 (230.2 - 259.2) 232 174.1 (163.6 - 185.3) 209 
Cumberland 176.9 (170.5 - 183.6) 581 223.5 (212.1 - 235.3) 300 147.8 (140.0 - 156.0) 282 
Downeast 190.7 (179.9 - 202.1) 238 234.6 (216.4 - 254.2) 127 161.7 (148.2 - 176.3) 111 
Midcoast 176.5 (168.4 - 184.9) 369 215.1 (201.5 - 229.4) 194 149.9 (139.9 - 160.6) 174 
Penquis 194.7 (186.1 - 203.5) 396 239.8 (225.3 - 255.0) 212 162.2 (151.8 - 173.3) 183 
Western 196.3 (188.4 - 204.5) 471 242.3 (228.8 - 256.3) 252 165.1 (155.3 - 175.3) 220 
York 180.4 (172.9 - 188.3) 436 221.9 (209.0 - 235.4) 230 152.4 (143.1 - 162.2) 207 
Maine 187.7 (184.8 - 190.7) 3,135 231.1 (226.1 - 236.2) 1,653 158.3 (154.7 - 162.0) 1,481 
 
Notes:  
•                County/District rate is significantly higher than Maine rate 
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population 
• Abbreviations: AA = Age-adjusted; CI = Confidence Interval; Count/Yr = Average Annual Count 
 
Data Sources: 
• National Center for Health Statistics, All Causes of Death, Public-Use with County, Total U.S. (1969-2010) 
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Lung Cancer: Mortali ty by County of Residence, Maine 2006-2010 
 
Total Male Female 
AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Androscoggin 60.8 (54.8 - 67.3) 75 71.9 (62.0 - 82.8) 40 52.3 (44.8 - 60.7) 36 
Aroostook 60.4 (54.0 - 67.6) 64 83.3 (71.9 - 96.2) 39 43.2 (35.8 - 51.8) 25 
Cumberland 51.6 (48.1 - 55.3) 166 67.0 (60.8 - 73.6) 90 41.3 (37.2 - 45.8) 77 
Franklin 58.9 (48.5 - 71.1) 23 72.4 (55.4 - 93.3) 13 48.1 (35.6 - 64.1) 10 
Hancock 52.2 (45.1 - 60.3) 39 57.8 (46.7 - 71.0) 20 48.4 (39.2 - 59.5) 20 
Kennebec 60.2 (54.7 - 66.1) 90 72.4 (63.4 - 82.3) 48 50.9 (44.2 - 58.4) 42 
Knox 46.4 (38.9 - 55.1) 28 60.8 (48.1 - 76.1) 16 35.0 (26.4 - 46.2) 12 
Lincoln 45.3 (37.6 - 54.3) 26 53.4 (41.1 - 68.9) 13 40.4 (30.8 - 52.8) 12 
Oxford 60.7 (53.1 - 69.1) 47 77.8 (65.0 - 92.5) 27 48.4 (39.4 - 59.3) 20 
Penobscot 63.2 (58.1 - 68.7) 112 79.5 (70.8 - 89.0) 63 50.6 (44.4 - 57.4) 49 
Piscataquis 54.1 (42.3 - 68.9) 15 73.6 (53.5 - 100.1) 9 37.7 (24.6 - 56.9) 5 
Sagadahoc 60.8 (50.8 - 72.3) 27 66.5 (50.9 - 85.6) 13 57.2 (44.3 - 72.9) 14 
Somerset 61.1 (52.9 - 70.2) 41 79.7 (65.8 - 95.9) 24 46.8 (37.4 - 58.2) 17 
Waldo 56.1 (47.0 - 66.6) 27 61.8 (47.5 - 79.2) 13 51.8 (40.2 - 66.1) 14 
Washington 63.8 (54.1 - 75.0) 32 80.4 (64.3 - 99.9) 18 52.0 (40.3 - 66.7) 14 
York 51.2 (47.2 - 55.5) 124 62.9 (56.1 - 70.2) 66 43.0 (38.1 - 48.4) 57 
Maine 56.1 (54.5 - 57.8) 937 69.9 (67.2 - 72.8) 513 46.0 (44.1 - 48.1) 424 
Lung Cancer: Mortality by Public Health District of Residence, Maine 2006-2010 
 
Total Male Female 
AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Aroostook 60.4 (54.0 - 67.6) 64 83.3 (71.9 - 96.2) 39 43.2 (35.8 - 51.8) 25 
Central 60.4 (55.8 - 65.2) 131 74.5 (66.9 - 82.8) 72 49.6 (44.1 - 55.7) 59 
Cumberland 51.6 (48.1 - 55.3) 166 67.0 (60.8 - 73.6) 90 41.3 (37.2 - 45.8) 77 
Downeast 56.6 (50.8 - 63.0) 71 66.6 (57.2 - 77.2) 37 49.5 (42.2 - 57.9) 34 
Midcoast 51.4 (47.1 - 56.1) 108 60.0 (53.1 - 67.7) 56 45.4 (39.9 - 51.5) 52 
Penquis 62.0 (57.2 - 67.0) 127 78.6 (70.5 - 87.3) 72 48.9 (43.3 - 55.2) 55 
Western 60.4 (56.0 - 65.0) 146 73.8 (66.6 - 81.6) 80 50.4 (45.0 - 56.3) 66 
York 51.2 (47.2 - 55.5) 124 62.9 (56.1 - 70.2) 66 43.0 (38.1 - 48.4) 57 
Maine 56.1 (54.5 - 57.8) 937 69.9 (67.2 - 72.8) 513 46.0 (44.1 - 48.1) 424 
 
Notes:  
•                County/District rate is significantly higher than Maine rate 
• Mortality case definitions are based on ICD-10 codes (See page 3) 
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population 
• Abbreviations: AA = Age-adjusted; CI = Confidence Interval; Count/Yr = Average Annual Count 
 
Data Sources: 
• National Center for Health Statistics, All Causes of Death, Public-Use with County, Total U.S. (1969-2010) 
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Tobacco-related Cancers, Excl. Lung: Mortali ty by County of Residence, Maine 2006-
2010 
 Total Male Female 
 AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Androscoggin 42.8 (37.8 - 48.4) 53 61.7 (52.4 - 72.1) 33 27.9 (22.7 - 34.1) 21 
Aroostook 37.3 (32.2 - 43.2) 39 49.4 (40.4 - 59.9) 22 28.5 (22.6 - 35.9) 16 
Cumberland 35.3 (32.5 - 38.3) 117 51.6 (46.3 - 57.4) 72 23.4 (20.4 - 26.8) 45 
Franklin 35.1 (27.2 - 44.7) 14 39.1 (26.9 - 55.3) 7 32.2 (22.1 - 45.9) 7 
Hancock 31.6 (26.2 - 38.0) 24 49.5 (39.0 - 62.1) 16 18.3 (13.1 - 25.5) 8 
Kennebec 41.4 (36.9 - 46.4) 62 59.0 (50.8 - 68.1) 39 27.8 (22.8 - 33.6) 23 
Knox 36.8 (30.1 - 44.7) 22 57.9 (45.4 - 73.0) 15 19.1 (13.0 - 27.7) 7 
Lincoln 31.9 (25.5 - 39.6) 18 39.6 (29.2 - 53.1) 10 25.5 (18.1 - 35.8) 8 
Oxford 45.6 (39.0 - 53.0) 35 67.2 (55.4 - 81.0) 23 28.2 (21.4 - 36.9) 12 
Penobscot 34.3 (30.5 - 38.4) 61 47.1 (40.4 - 54.7) 36 24.6 (20.4 - 29.5) 25 
Piscataquis 38.4 (28.5 - 51.3) 10 53.1 (35.9 - 76.8) 7 27.1 (16.3 - 44.2) 4 
Sagadahoc 35.4 (27.8 - 44.6) 15 48.6 (35.3 - 65.3) 9 24.9 (16.6 - 36.1) 6 
Somerset 39.2 (32.7 - 46.8) 26 49.8 (39.0 - 62.8) 15 30.0 (22.5 - 39.6) 11 
Waldo 33.0 (26.2 - 41.3) 16 46.6 (34.3 - 62.0) 10 21.8 (14.7 - 31.6) 6 
Washington 42.5 (34.6 - 52.0) 21 63.3 (48.9 - 81.0) 14 25.8 (17.7 - 37.0) 7 
York 37.5 (34.1 - 41.2) 91 56.4 (50.0 - 63.4) 59 22.8 (19.4 - 26.8) 32 
Maine 37.3 (35.9 - 38.6) 624 53.2 (50.8 - 55.6) 388 24.9 (23.5 - 26.4) 236 
Tobacco-related Cancers, Excl. Lung: Mortality by Public Health District of Residence, Maine 
2006-2010 
 Total Male Female 
 AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Aroostook 37.3 (32.2 - 43.2) 39 49.4 (40.4 - 59.9) 22 28.5 (22.6 - 35.9) 16 
Central 40.8 (37.0 - 44.9) 88 56.3 (49.7 - 63.6) 54 28.5 (24.3 - 33.3) 34 
Cumberland 35.3 (32.5 - 38.3) 117 51.6 (46.3 - 57.4) 72 23.4 (20.4 - 26.8) 45 
Downeast 35.7 (31.1 - 40.9) 45 54.7 (46.1 - 64.6) 30 21.1 (16.5 - 26.8) 15 
Midcoast 34.3 (30.7 - 38.1) 72 48.1 (41.9 - 55.1) 45 22.6 (18.9 - 26.9) 27 
Penquis 34.9 (31.3 - 38.8) 71 48.0 (41.6 - 55.1) 43 25.0 (21.0 - 29.6) 28 
Western 42.5 (38.8 - 46.4) 102 59.8 (53.2 - 66.9) 63 28.8 (24.9 - 33.3) 39 
York 37.5 (34.1 - 41.2) 91 56.4 (50.0 - 63.4) 59 22.8 (19.4 - 26.8) 32 
Maine 37.3 (35.9 - 38.6) 624 53.2 (50.8 - 55.6) 388 24.9 (23.5 - 26.4) 236 
 
Notes:  
•                County/District rate is significantly higher than Maine rate 
• Mortality case definitions are based on ICD-10 codes (See page 3) 
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population 
• Abbreviations: Excl. = Excluding; AA = Age-adjusted; CI = Confidence Interval; Count/Yr = Average Annual Count 
 
Data Sources: 
• National Center for Health Statistics, All Causes of Death, Public-Use with County, Total U.S. (1969-2010) 
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Prostate Cancer: Mortali ty by County of 













Prostate Cancer: Mortality by Public Health 




AA Rate (95% CI) Count/Yr 
Aroostook 14.0 (9.2 - 20.5) 6 
Central 25.4 (20.8 - 30.8) 21 
Cumberland 24.6 (20.8 - 28.9) 30 
Downeast 28.1 (21.8 - 35.7) 14 
Midcoast 25.2 (20.6 - 30.6) 21 
Penquis 22.5 (18.0 - 27.8) 18 
Western 21.1 (17.1 - 25.8) 20 
York 20.1 (16.1 - 24.7) 18 







• Mortality case definitions are based on ICD-10 codes (See page 3) 
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population 
• Abbreviations: AA = Age-adjusted; CI = Confidence Interval; Count/Yr = Average Annual Count 
 
Data Sources: 







AA Rate (95% CI) Count/Yr 
Androscoggin 20.3 (14.9 - 27.0) 10 
Aroostook 14.0 (9.2 - 20.5) 6 
Cumberland 24.6 (20.8 - 28.9) 30 
Franklin 25.3 (14.9 - 40.2) 4 
Hancock 30.6 (22.3 - 41.1) 9 
Kennebec 27.7 (21.9 - 34.4) 16 
Knox 24.7 (16.7 - 35.5) 6 
Lincoln 24.5 (16.2 - 36.0) 6 
Oxford 20.6 (14.0 - 29.3) 6 
Penobscot 22.8 (17.9 - 28.6) 15 
Piscataquis 20.8 (10.3 - 38.7) 2 
Sagadahoc 29.5 (18.7 - 44.0) 5 
Somerset 19.6 (12.7 - 29.0) 5 
Waldo 23.7 (14.6 - 36.4) 4 
Washington 24.0 (15.3 - 36.2) 5 
York 20.1 (16.1 - 24.7) 18 
Maine 22.9 (21.3 - 24.7) 148 
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Female Breast Cancer: Mortality by County 
of Residence, Maine 2006-2010 
 Female 
 AA Rate (95% CI) Count/Yr 
Androscoggin 22.0 (17.2 - 27.7) 15 
Aroostook 22.3 (16.9 - 29.1) 12 
Cumberland 19.4 (16.7 - 22.6) 37 
Franklin 15.3 (8.8 - 25.3) 3 
Hancock 22.1 (16.0 - 30.2) 9 
Kennebec 24.4 (19.7 - 30.0) 20 
Knox 26.8 (19.1 - 37.0) 9 
Lincoln 14.3 (8.9 - 22.9) 4 
Oxford 25.1 (18.7 - 33.2) 11 
Penobscot 19.6 (15.8 - 24.0) 19 
Piscataquis 19.5 (10.9 - 34.4) 3 
Sagadahoc 21.3 (13.7 - 32.1) 5 
Somerset 18.4 (12.7 - 26.1) 7 
Waldo 22.2 (14.8 - 32.3) 6 
Washington 22.9 (15.2 - 33.9) 6 
York 20.0 (16.7 - 23.8) 27 





Female Breast Cancer: Mortali ty by 
Public Health District  of Residence, 
Maine 2006-2010 
 Female 
 AA Rate (95% CI) Count/Yr 
Aroostook 22.3 (16.9 - 29.1) 12 
Central 22.6 (18.8 - 26.9) 26 
Cumberland 19.4 (16.7 - 22.6) 37 
Downeast 22.5 (17.6 - 28.7) 15 
Midcoast 21.3 (17.5 - 25.7) 24 
Penquis 19.6 (16.1 - 23.8) 22 
Western 21.8 (18.4 - 25.8) 29 
York 20.0 (16.7 - 23.8) 27 










• Mortality case definitions are based on ICD-10 codes (See page 3) 
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population 
• Abbreviations: AA = Age-adjusted; CI = Confidence Interval; Count/Yr = Average Annual Count 
 
Data Sources: 
• National Center for Health Statistics, All Causes of Death, Public-Use with County, Total U.S. (1969-2010) 
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Colorectal Cancer: Mortali ty by County of Residence, Maine 2006-2010 
 Total Male Female 
 AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Androscoggin 14.4 (11.6 - 17.8) 18 20.9 (15.5 - 27.4) 11 10.4 (7.2 - 14.5) 7 
Aroostook 20.8 (17.1 - 25.2) 22 22.1 (16.2 - 29.6) 10 19.7 (15.0 - 25.7) 12 
Cumberland 16.0 (14.1 - 18.1) 53 20.1 (16.8 - 23.8) 27 13.1 (10.9 - 15.6) 26 
Franklin 27.5 (20.2 - 36.7) 10 35.9 (23.4 - 52.8) 5 22.2 (13.6 - 34.6) 4 
Hancock 11.8 (8.6 - 16.0) 9 11.9 (7.2 - 18.9) 4 11.8 (7.7 - 17.9) 5 
Kennebec 18.9 (15.9 - 22.3) 29 21.3 (16.5 - 27.1) 14 17.0 (13.3 - 21.5) 15 
Knox 12.1 (8.5 - 16.9) 8 16.2 (9.9 - 25.2) 4 9.2 (5.3 - 15.8) 3 
Lincoln 14.0 (9.9 - 19.5) 8 19.8 (12.6 - 30.2) 5 9.3 (5.2 - 16.5) 3 
Oxford 17.5 (13.5 - 22.4) 13 20.2 (13.9 - 28.5) 7 15.3 (10.3 - 22.1) 6 
Penobscot 16.7 (14.1 - 19.6) 30 21.1 (16.7 - 26.4) 16 13.6 (10.5 - 17.4) 13 
Piscataquis 22.8 (15.1 - 33.7) 6 32.2 (18.6 - 53.0) 4 15.3 (7.6 - 29.5) 2 
Sagadahoc 14.4 (9.8 - 20.5) 7 18.0 (10.3 - 29.4) 3 12.1 (6.8 - 20.4) 3 
Somerset 19.9 (15.4 - 25.6) 13 20.5 (13.7 - 29.6) 6 18.5 (12.9 - 26.2) 7 
Waldo 15.2 (10.7 - 21.1) 8 23.1 (14.5 - 35.0) 5 10.1 (5.5 - 17.5) 3 
Washington 13.4 (9.1 - 19.3) 6 20.3 (12.4 - 31.7) 4 8.2 (4.0 - 15.8) 2 
York 15.9 (13.7 - 18.3) 39 17.4 (13.9 - 21.6) 18 14.8 (12.1 - 18.1) 21 
Maine 16.5 (15.7 - 17.4) 278 20.2 (18.7 - 21.8) 143 13.9 (12.9 - 15.0) 135 
Colorectal Cancer: Mortality by Public Health District of Residence, Maine 2006-2010 
 Total Male Female 
 AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr AA Rate (95% CI) Count/Yr 
Aroostook 20.8 (17.1 - 25.2) 22 22.1 (16.2 - 29.6) 10 19.7 (15.0 - 25.7) 12 
Central 19.2 (16.7 - 22.0) 42 21.1 (17.1 - 25.8) 20 17.4 (14.2 - 21.1) 22 
Cumberland 16.0 (14.1 - 18.1) 53 20.1 (16.8 - 23.8) 27 13.1 (10.9 - 15.6) 26 
Downeast 12.4 (9.8 - 15.6) 16 15.1 (10.8 - 20.8) 8 10.3 (7.2 - 14.5) 7 
Midcoast 13.8 (11.7 - 16.3) 30 19.1 (15.2 - 23.7) 17 10.1 (7.7 - 13.1) 13 
Penquis 17.4 (14.9 - 20.2) 35 22.5 (18.2 - 27.6) 20 13.7 (10.8 - 17.3) 16 
Western 17.3 (15.0 - 19.9) 41 23.0 (18.9 - 27.7) 23 13.6 (10.9 - 16.8) 18 
York 15.9 (13.7 - 18.3) 39 17.4 (13.9 - 21.6) 18 14.8 (12.1 - 18.1) 21 
Maine 16.5 (15.7 - 17.4) 278 20.2 (18.7 - 21.8) 143 13.9 (12.9 - 15.0) 135 
 
Notes:  
•                County/District rate is significantly higher than Maine rate 
• Mortality case definitions are based on ICD-10 codes (See page 3) 
• Rates are calculated per 100,000 population and age-adjusted to the year 2000 U.S. standard population 
• Abbreviations: AA = Age-adjusted; CI = Confidence Interval; Count/Yr = Average Annual Count 
 
Data Sources: 
• National Center for Health Statistics, All Causes of Death, Public-Use with State, Total U.S. (1969-2010) 
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Age-adjusted Cancer Mortali ty Trend: All Malignant Cancers, Maine 1969-2010 
 
 
Age-adjusted Cancer Mortality Trend: All Malignant Cancers, U.S. and Maine 1969-2010 
 
Data Source:  
• National Center for Health Statistics, All Causes of Death, Public-Use with State, Total U.S. (1969-2010) 
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Age-adjusted Cancer Mortality Trend: Top Causes of Cancer among Males, Maine 1969-2010 
 
Age-adjusted Cancer Mortali ty Trend: Top Causes of Cancer among Females, Maine 
1969-2010   
  
Data Source:  
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APPENDIX 1 
I N C I D E N C E  C A S E  D E F I N I T I O N S  
Incidence data are based on SEER site recode ICD-O-3/WHO 2008 definitions, version 2008. Available at 
http://www.seer.cancer.gov/siterecode/icdo3_dwhoheme/index.html.   
Site Recode ICD-O-3/WHO 2008 Definition*^ 
Site Group ICD-O-3 Site ICD-O-3 Histology (Type) Recode 
 
Oral Cavity and Pharynx 
 
         
    Lip 
 
C000-C009  excluding 9050-9055, 9140, 9590-9992 20010  
    Tongue 
 
C019-C029  20020  
    Salivary Gland 
 
C079-C089  20030  
    Floor of Mouth 
 
C040-C049  20040  





    Nasopharynx 
 
C110-C119  20060  
    Tonsil 
 
C090-C099  20070  
    Oropharynx 
 
C100-C109  20080  
    Hypopharynx 
 
C129, C130-C139  20090  
    Other Oral Cavity and 
Pharynx  
 




         
    Esophagus 
 
C150-C159  excluding 9050-9055, 9140, 9590-9992 21010  
    Stomach 
 
C160-C169  21020  
    Small Intestine 
 
C170-C179  21030  
    Colon and Rectum 
 
         
        Colon excluding Rectum 
 
         
            Cecum 
 
C180  excluding 9050-9055, 9140, 9590-9992 21041  
            Appendix 
 
C181  21042  
            Ascending Colon 
 
C182  21043  
            Hepatic Flexure 
 
C183  21044  
            Transverse Colon 
 
C184  21045  
            Splenic Flexure 
 
C185  21046  
            Descending Colon 
 
C186  21047  
            Sigmoid Colon 
 
C187  21048  
            Large Intestine, NOS 
 
C188-C189, C260  21049  
        Rectum and Rectosigmoid 
Junction  
 
         
            Rectosigmoid Junction
 
C199  excluding 9050-9055, 9140, 9590-9992 21051  
            Rectum 
 
C209  21052  
    Anus, Anal Canal and 
Anorectum  
 
C210-C212, C218  21060  
    Liver and Intrahepatic Bile 
Duct  
 
         
        Liver 
 
C220  excluding 9050-9055, 9140, 9590-9992 21071  
        Intrahepatic Bile Duct 
 
C221  21072  
    Gallbladder 
 
C239  21080  
    Other Biliary 
 
C240-C249  21090  
    Pancreas 
 
C250-C259  21100  
    Retroperitoneum 
 
C480  21110  
    Peritoneum, Omentum and 
Mesentery  
 
C481-C482  21120  
    Other Digestive Organs 
 
C268-C269, C488  21130  





         
    Nose, Nasal Cavity and 
Middle Ear  
 
C300-C301, C310-C319  excluding 9050-9055, 9140, 9590-9992 22010  
    Larynx 
 
C320-C329  22020  
    Lung and Bronchus 
 
C340-C349  22030  
    Pleura 
 
C384  22050  
    Trachea, Mediastinum and 
Other Respiratory Organs  
 
C339, C381-C383, C388, 
C390, C398, C399  
22060  
 
Bones and Joints 
 
C400-C419  excluding 9050-9055, 9140, 9590-9992 23000  
 




excluding 9050-9055, 9140, 9590-9992 24000  
 
Skin excluding Basal and 
Squamous  
 
         
    Melanoma of the Skin 
 
C440-C449  8720-8790  25010  
    Other Non-Epithelial Skin 
 
C440-C449  excluding 8000-8005, 8010-8046, 8050-8084, 8090-





C500-C509  excluding 9050-9055, 9140, 9590-9992 26000  
 
Female Genital System 
 
         
    Cervix Uteri 
 
C530-C539  excluding 9050-9055, 9140, 9590-9992 27010  
    Corpus and Uterus, NOS 
 
         
        Corpus Uteri 
 
C540-C549  excluding 9050-9055, 9140, 9590-9992 27020  
        Uterus, NOS 
 
C559  27030  
    Ovary 
 
C569  27040  
    Vagina 
 
C529  27050  
    Vulva 
 
C510-C519  27060  
    Other Female Genital Organs 
 
C570-C589  27070  
 
Male Genital System 
 
         
    Prostate 
 
C619  excluding 9050-9055, 9140, 9590-9992 28010  
    Testis 
 
C620-C629  28020  
    Penis 
 
C600-C609  28030  
    Other Male Genital Organs 
 




         
    Urinary Bladder 
 
C670-C679  excluding 9050-9055, 9140, 9590-9992 29010  
    Kidney and Renal Pelvis 
 
C649, C659  29020  
    Ureter 
 
C669  29030  
    Other Urinary Organs 
 
C680-C689  29040  
 
Eye and Orbit 
 
C690-C699  excluding 9050-9055, 9140, 9590-9992 30000  
 
Brain and Other Nervous 
System  
 
         
    Brain 
 
C710-C719  excluding 9050-9055, 9140, 9530-9539, 9590-9992 31010  
    Cranial Nerves Other 
Nervous System  
 
C710-C719  9530-9539  31040  




         
    Thyroid 
 
C739  excluding 9050-9055, 9140, 9590-9992 32010  









         
    Hodgkin Lymphoma 
 
         
        Hodgkin - Nodal 
 
C024, C098-C099, C111, 
C142, C379, C422, C770-
C779  
9650-9667  33011  
        Hodgkin - Extranodal 
 
All other sites  33012  
    Non-Hodgkin Lymphoma 
 
         





9590-9597, 9670-9671, 9673, 9675, 9678-9680, 9684, 
9687-9691, 9695, 9698-9702, 9705, 9708-9709, 9712, 
9714-9719, 9724-9729, 9735, 9737-9738, 9811-9818, 
9823, 9827, 9837  
33041  
        NHL - Extranodal 
 
All sites except C024, C098- 9590-9597, 9670-9671, 9673, 9675, 9678-9680, 9684, 33042  
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C099, C111, C142, C379, 
C422, C770-C779  
9687-9691, 9695, 9698-9702, 9705, 9708-9709, 9712, 
9714-9719, 9724-9729, 9735, 9737-9738  
All sites except C024, C098-
C099, C111, C142, C379, 
C420-C422, C424, C770-
C779  








         
    Lymphocytic Leukemia 
 
         
        Acute Lymphocytic 
Leukemia  
 
   9826, 9835-9836  35011  
C420, C421, C424  9811-9818, 9837  
        Chronic Lymphocytic 
Leukemia  
 
C420, C421, C424  9823  35012  
        Other Lymphocytic 
Leukemia  
 
   9820, 9832-9834, 9940  35013  
    Myeloid and Monocytic 
Leukemia  
 
         
        Acute Myeloid Leukemia 
 
   9840, 9861, 9865-9867, 9869, 9871-9874, 9895-9897, 
9898, 9910-9911, 9920  
35021  
        Acute Monocytic Leukemia 
 
   9891  35031  
        Chronic Myeloid Leukemia 
 
   9863, 9875-9876, 9945-9946  35022  
        Other Myeloid/Monocytic 
Leukemia  
 
   9860, 9930  35023  
    Other Leukemia 
 
         
        Other Acute Leukemia 
 
   9801, 9805-9809, 9931  35041  
        Aleukemic, subleukemic 
and NOS  
 
   9733, 9742, 9800, 9831, 9870, 9948, 9963-9964  35043  












   9740-9741, 9750-9769, 9950, 9960-9962, 9965-9967, 
9970-9971, 9975, 9980, 9982-9987, 9989, 9991-9992 
37000  






Site or histology code not within valid range or site code not found in this table.  99999  
* This table was updated for Hematopoietic codes based on WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 
(2008). 





















The Department of Health and Human Services (DHHS) does not discriminate on the basis of disability, race, color, 
creed, gender, sexual orientation, age, or national origin, in admission to, access to, or operations of its programs, 
services, or activities, or its hiring or employment practices.  This notice is provided as required by Title II of the 
Americans with Disabilities Act of 1990 and in accordance with the Civil Rights Act of 1964 as amended, Section 
504 of the Rehabilitation Act of 1973, as amended, the Age Discrimination Act of 1975, Title IX of the Education 
Amendments of 1972 and the Maine Human Rights Act and Executive Order Regarding State of Maine Contracts 
for Services.  Questions, concerns, complaints or requests for additional information regarding the ADA may be 
forwarded to DHHS’ ADA Compliance/EEO Coordinators, 11 State House Station – 221 State Street, Augusta, 
Maine 04333, 207-287-4289 (V), 207-287-3488 (V), TTY users call Maine relay 711.  Individuals who need 
auxiliary aids for effective communication in program and services of DHHS are invited to make their needs and 
preferences known to the ADA Compliance/EEO Coordinators.  This notice is available in alternate formats, upon 
request. 
 
 
